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PREFACE 
The purpose of this study was to develop an inexpensive, 
short-term assay to determine the effect of chemicals on gene 
expression 1n oocytes of the South African Clawed Frog, Xenopus 
laevis. This assay was designed to complement the teratogenicity 
testing of these same test compounds using Xenopus embryos in order 
to define a molecular basis of teratogenicity. This permits the effect 
of a test agent on gene expression in the oocyte to be compared to the 
effect of the substance on the growth and development of the 
Xenopus embryo. 
This dissertation is divided into four chapters. An introduction 
to this work is presented in Chapter I, followed by a review of the 
literature in Chapter II. Chapters III and IV are separate and 
complete manuscripts prepared for submission to the journal, 
Teratogenesis, Carcinogenesis, and Mutagenesis. The use of 
Xenopus oocytes as a short-term genotoxicity assay is presented in 
Chapter III while the use of Xenopus embryos in short-term 
teratogenicity testing is presented in Chapter IV. 
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CHAPTER I 
INTRODUCTION 
Statement of Problem 
All living organisms, with the exception of many viruses, contain 
DNA. The arrangement of the four nucleotide bases composing DNA, 
adenine, guanine, cytosine, and thymine, into units called genes, 
determines the blueprint for proper cellular function. Genes are 
transcribed into RNA, and if the RNA is the messenger type, the 
sequence of its bases will determine the order of amino acids composing 
a protein. Changes in the nucleotide sequence of DNA or in the ability 
of the DNA to be properly expressed can have deleterious effects on the 
cellular products that the DNA encodes. Therefore, it is important 
that the genetic information of a cell be replicated, transcribed, and 
translated in a precise manner. This is especially crucial during 
embryonic development since the rapid growth, multiplication, and 
differentiation of cells depends on the accurate replication of DNA and 
the expression of specific genes. Agents which interfere with the 
informational flow of DNA to protein may cause abnormal development or 
be teratogenic to developing embryos. 
Because of the increasing number of chemicals being introduced 
into the environment each year, it is important to develop short-term 
tests which can identify agents that alter the normal genetic 
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expression or composition of DNA in living organisms which may lead to 
abnormal development. While a substance may not itself be hazardous, 
chemical decomposition in the environment or metabolism within the 
organism may produce a harmful product. Many tests have already been 
developed to identify substances in the environment that are mutagenic 
to living organisms in that they are able to cause a heritable change 
in the structure of DNA. Compounds that cause mutations or genetic 
alterations in the DNA have been positively correlated with 
carcinogenicity (1-3). The term genotoxic in the traditional sense 
refers to substances that cause changes in the DNA which may lead to 
cancer in the organism (4). However, this definition may be somewhat 
limiting. There are many steps involved in gene expression including 
transcription, processing and transport, and translation. At each of 
these levels a substance could interrupt the normal flow of information 
from gene to product. Therefore, a genotoxin will be defined in this 
study as a substance that interferes with the normal expression of a 
gene into its final product. 
Objectives 
Few, if any assays, have specifically been designed to study the 
effect of test agents on gene expression as a biochemical basis of 
teratogenicity. The purpose of this study was to develop an 
inexpensive, short-term genotoxicity assay to determine the effect of 
test compounds on gene expression in oocytes of the South African 
Clawed Frog, Xenopus laevis. The assay was designed to 
complement the data obtained from the teratogenicity testing of these 
same test compounds using Xenopus embryos. This permits the effect 
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of a test substance on gene expression in the oocyte to be compared to 
the effect of the test compound on the growth and development of the 
Xenopus embryo. 
General Strategy 
Experimental Design for Detecting 
Genotoxic Agents 
The genotoxicity assay described in this dissertation used the 
cloned herpes thymidine kinase (TK) gene as a molecular probe to 
examine the effects of known inhibitors of DNA, RNA, and protein 
synthesis on the expression the viral TK gene in Xenopus oocytes. 
The TK gene was selected not only because it was commercially available 
as an insert in an Escherichia coli plasmid, but also because it 
had been extremely well characterized and shown to be expressed 10 the 
Xenopus oocyte. The Xenopus oocyte will transcribe the viral 
TK gene into RNA and translate the RNA into functional protein. The 
ability of a test compound to change the expression of the TK gene in 
Xenopus oocytes was determined by measuring the amount of 
functional TK produced in two different tests referred to as the Gene 
Exposure Assay and Oocyte Exposure Assay. 
Gene Exposure Assay 
The Gene Exposure Assay measures the ability of a test agent to 
alter the expression of the TK gene by damaging the DNA. Such damage 
could result from the intercalation of the substance into the DNA or 
possibly by altering the nucleotide sequence composing the TK gene. In 
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the Gene Exposure Assay, the plasmid DNA containing the TK gene 
(pHSV106) was exposed for two hours to the test compound prior to 
injection. After this time, any test substance not bound to the DNA 
was removed by gel filtration chromatography. The DNA was concentrated 
by lyophilization. The oocytes were then injected with the DNA in the 
nucleus and allowed to incubate overnight to allow the synthesis of 
detectable quantities of TK. After incubation, the amount of TK 
produced in oocytes injected with DNA previously exposed to the test 
compound was compared with the amount of TK synthesized in oocytes 
injected with untreated DNA. 
Oocyte Exposure Assay 
The Oocyte Exposure Assay tests the ability of a substance to 
change the expression of the TK gene by inhibiting RNA or protein 
synthesis without necessarily affecting the DNA directly. For this 
assay, pHSV106 DNA was injected directly into oocyte nuclei. The 
plasmid DNA was not exposed prior to microinjection. The oocytes were 
then exposed to different concentrations of the test substance. After 
24 hours, the amount of TK synthesized in oocytes exposed to the test 
agent was compared to the amount of TK synthesized in oocytes injected 
with DNA not exposed to the test compound. 
Significance of the Gene Exposure and 
Oocyte Exposure Assays and Relevance 
to Teratogenicity Testing 
The proposed Gene and Oocyte Exposure Assays (referred to 
collectively as the Xenopus Oocyte Assays) are useful because 
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jointly they identify substances which damage the DNA as indicated 
byaltered expression of the TK gene and because they identify agents 
which affect transcriptional and translational processes. Most, if not 
all, current genotoxicity assays measure only DNA damage that results, 
either directly or indirectly, from mutational events. In this sense, 
the Xenopus Oocyte Assays are not traditional genotoxicity tests 
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since DNA damage detected in the Gene Exposure Assay may not 
necessarily be due to a mutation and changes in gene expression 
observed in the Oocyte Exposure Assay may not be due to DNA damage at 
all. However, the Xenopus Oocyte Assays are novel in that they can 
monitor the flow of genetic information into protein. Compounds which 
produce changes in gene expression may be teratogenic or cause abnormal 
development. Because the oocyte is destined on fertilization to divide 
and differentiate into an embryo, we can confirm with teratogenicity 
tests whether the deleterious effect of a test substance on gene 
expression in the oocyte is predictive of malformation and death of the 
organism later in development. Therefore, the Xenopus Oocyte 
Genotoxicity Assays are relevant to Xenopus teratogenicity tests as 
well. 
By evaluating both the genotoxic and teratogenic potential of a 
test substance in Xenopus, the chance that a hazardous compound 
will escape detection is reduced. This makes the proposed Xenopus 
system a more predictive indicator of toxicity and decreases the 
frequency of false negatives or positives which may result from using 
the molecular assay alone. Moreover, the molecular assay strongly 
complements the teratogenicity assay since it may reveal genetic damage 
that is not expressed as an observable physical abnormality. 
Experimental Design for Detecting 
Teratogenic Agents 
Xenopus laevis embryos ~ere used by Dumont and coworkers 
as an organism for teratogenicity studies for several years (5-7) prior 
to the use of Xenopus embryos in teratogenicity experiments in this 
laboratory. Dumont et al. (7) named this system FETAX (Frog Embryo 
Teratogenesis Assay-Xenopus). The development of the FETAX assay 
provides a strong foundation for the building of ancillary tests which 
attempt to define a biochemical basis for teratogenicity in 
Xenopus. In order to measure the teratogenic potential of a 
substance, Xenopus embryos in the late blastula to early gastrula 
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stage were placed in different concentrations of toxicant. 
Malformation, growth, and lethality were measured every 24 hours for 96 
hours. The teratogenicity index (TI) was calculated by dividing the 
LC50 (lethal concentration which kills 50% of the embryos) by the EC50 
for malformation (effective concentration which causes malformation in 
50% of the embryos) according to Dumont et al. (7). A high TI 
indicates that a compound is teratogenic since it causes malformation 
at much lower concentrations than are required to kill the organism. A 
TI of 1 means that the substance is not teratogenic since death and 
malformation occur' at identical concentrations. In this case, the 
substance should be considered cytotoxic. 
In order to determine whether the teratogenic action of a test 
agent can be linked to its ability to interfere with gene expression, 
the oocytes are exposed to a concentration similar to the LC50 value 
obtained during the teratogenicity testing of the compound. If the 
LC50 concentration observed in the FETAX assay does not affect gene 
expression in the Gene Exposure Assay or Oocyte Exposure Assay, then 
this suggests that the test substance does not act as a teratogen by 
affecting gene expression. If gene expression is affected by the 
teratogen, then the substance is also a genotoxicant. The Gene 
Exposure Assay will identify teratogens which damage DNA while the 
Oocyte Exposure Assay will identify teratogens which act by affecting 
either RNA and/or protein synthesis. 
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CHAPTER II 
LITERATURE REVIEW 
The Short-Term Genotoxicity Assays 
Approaches to Short-Term Testing 
Many short-term genotoxicity assays are currently available to 
identify genetically hazardous substances in the environment. All have 
advantages and disadvantages. For this reason, a battery of short-
term assays are generally performed to evaluate the toxicity of a 
substance. The battery approach 1s considered superior to the tier 
strategy (see 8 for review). In the tier system, chemicals are 
initially screened with an inexpensive short-term test. On the basis 
of this single test those substances yielding positive results are then 
subjected to longer, more expensive studies. Since a false negative 
could occur during initial screening, the likelihood that a mutagen 
will escape detection is higher with the tier approach than in battery 
testing where the results of many different short-term assays are used 
to assess toxicity. 
The short-term genotoxicity assays can be divided into four 
general classes. These include assays for gene mutation, chromosomal 
aberrations, DNA repair, and oncogenic transformation. Both in 
vivo and in vitro gene mutation assays have been developed 
using microbial, mammalian, and insect species. The following 
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discussion of short-term assays is to provide the reader with an 
overview of the most commonly used genotoxicity assays. The discussion 
should not be considered inclusive of all assays presently available. 
Prokaryotic Gene Mutation Assays 
The earliest described microbial gene mutation assays used 
streptomycin-dependent strains of.!!.. coli which were back 
mutated to streptomycin-independence if the chemical was mutagenic (9). 
This test was improved by Inyer and Szybalski (10). However, it was 
later determined that base-pair substitution mutations could be 
detected with this method but frameshift mutations could not (11). 
Other.!!.. coli systems have also been described (see 12 for 
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review) which are based on the induction of mutations in the forward or 
reverse direction due to base-pair, frameshift, or small deletion 
mutations as detected by dependence or independence of the bacteria to 
streptomycin, tryptophan, arginine, galactose, or 5-methyltryptophan. 
The most recognized of the microbial procedures for detecting gene 
mutations is the Ames test (1-3). The Ames test in its simplest form 
measures the ability of a chemical to cause a histidine deficient 
Salmonella strain to revert. The appearance of histidine-
independent colonies is scored as a mutational event. Different types 
of Salmonella mutants are used thus permitting the type of mutation 
(base-substitution versus frameshift) caused by a chemical to be 
determined. There are many variations of the Salmonella 
mutagenicity assay system (13). 
The Ames test has several recognized advantages. It is a very 
rapid, inexpensive test, and can identify many mutagenic substances and 
link mutagenicity with carcinogenicity (1-3). However, the Ames assay 
is far from a definitive test for carcinogenicity (14) and also yields 
some false positive and false negative mutagenic responses (13). In 
addition, as in all bacterial assays, the Ames test measures mutations 
at only one gene locus and uses prokaryotes to extrapolate the effect 
of chemicals on higher organisms. 
The Limitations of Prokaryotes as Indicators of Genotox-
10 
icity to Mammals. It is important to realize the problem of using 
prokaryotes as indicators of toxicity to mammals. The eukaryotic 
genome is regulated quite differently from the prokaryotic genome. 
Prokaryotic genes are typically arranged in operons while eukaryotic 
genes are not (15). Recombinant DNA work has demonstrated the presence 
of intervening noncoding sequences in the middle of protein-coding 
sequences of eukaryotic genes (16). Many sites unique to eukaryotic 
DNA seem to regulate gene expression. These sites include DNA 
sequences which control transcription initiation and termination (17), 
splicing (16), and polyadenylation (17). There are many post-
transcriptional and translational controls which regulate gene 
expression in eukaryotes such as pre-mRNA cleavage and splicing, 5 1 
mRNA capping, mRNA methylation, polyadenylation, and mRNA recognition 
at the ribosomes (18). A chemical may not be toxic to the 
comparatively simple prokaryote but extremely deleterious to the 
eukaryote since it may act on any one of the many unique regulatory 
mechanisms involved in eukaryotic gene expression. Therefore, with the 
goal of being more relevant to higher eukaryotes, mammalian systems 
have been developed to screen for genotoxic chemicals. 
Mammalian Gene Mutation Assays 
In Vitro Mammalian Gene Mutation Assays. There are many 
in vitro mammalian gene mutation assays and all involve cell 
culture. One of the most popular systems utilizes the CHO or V79 cell 
lines derived from the Chinese hamster ovary and lung tissue, 
respectively (see 19-20 for review). Most studies using these cell 
lines employ the hypoxanthine-guanine phosphoribosyltransferase (HPGRT) 
gene loci to monitor mutational events by measuring the resistance of 
the cells to the purine analogs 8-azaguanine or 6-thioguanine (19-20). 
The HPGRT gene loci and ouabain resistance have been used as markers 
for mutant selection in mouse lymphoma L5178Y and human lymphoblast 
cells (19-20). The thymidine kinase gene has been used for gene 
mutation studies in mouse lymphoma L5178Y cells (19-20). 
While the mammalian cell culture assays may identify some 
mutagenic compounds the runes test does not (21), these test systems, 
like microbial assays, may be insensitive to some mutagens due to the 
highly specific natur~ of the lesion required to produce a response 
(20). Mutational events occurring along the DNA at points other than 
at the marker gene locus will go undetected. In addition, cell culture 
lines can be difficult and expensive to maintain. While mammalian cell 
culture systems provide data faster than long-term studies, a 
considerable amount of money, time, and labor is involved which reduces 
the number of chemicals that can be investigated at a particular time. 
In Vivo Mammalian Gene Mutation Assays. Several in 
vivo mammalian gene mutation assays are available. Two common 
assays are the somatic cell spot test and the specific locus test (see 
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19, 22 for review). The somatic cell spot test detects mutations at 
several coat color loci in strains of mice. Females are treated with 
the test compound ten days into pregnancy. Three to five weeks after 
parturition the offspring are scored for coat color spots due to 
mutation at the coat color loci (22). The spot test has several 
advantages. It can identify, using a conservative number of animals, 
mutations at more than one marker locus and provides information on the 
ability of a compound to cross the placental blood barrier (22). 
However, there are also disadvantages with this system. The test is 
long for a short-term assay, requiring three to five weeks for 
completion. Identification of true recessive spots can be difficult 
and the time of exposure of the animal to the test substance is 
critical since changes in the mutational frequency will result (22). 
The specific locus test crosses wild-type mice treated with the 
test compound with mice carrying multiple recessive traits. The Fl 
offspring will exhib.it the wild-type phenotype unless a mutation has 
occurred. Additional tests are performed on mice possessing mutant 
phenotypes to determine the nature and heritability of the mutagen. 
This test only identifies mutagens that cause phenotypic changes and it 
is difficult to determine the nature of the mutation in phenotypically 
altered mice (22). Moreover, large sample sizes are required and the 
test takes several weeks to perform. 
Another in vivo gene mutation assay uses Drosophila 
melanogaster and is called the SLRL assay since it detects 
induction of sex-linked recessive lethals in the second generation of 
treated individuals (see 12 for review). This test detects point 
mutations of all types (19) and offers several advantages. It covers a 
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wide range of genetic damage from point mutations to major deletions in 
the DNA, utilizes a eukaryotic organism, and activates test compounds 
to their mutagenic form. The major problem with the assay is 
quantitating the dose actually administered to the flies during 
feeding. In order to solve this problem, extensive preliminary 
toxicity and uptake studies are required to ensure that the chemical 
has been taken up by the flies (19). 
Assays Which Detect Chromosomal Aberrations 
Somatic Cell Assays. There are many somatic cell assays which 
measure the ability of a substance to cause chromosome damage. Three 
examples of somatic cell assays detecting DNA damage are somatic cell 
cytogenetics, the micronucleus test, and sister chromatid exchange (see 
22 for review). 
As reviewed by Soares (22) there are many cytogenetic assays 
utilizing somatic cells with well defined karyotypes. For example, 
human, chinese hamster, mouse, syrian hamster embryo, and rat liver 
cells have been used. Metaphase chromosomes are examined for the 
presence of aberrations including breaks, gaps, deletions, 
translocations, and ploidy changes (22). While these assays offer the 
advantage of providing direct observation of chromosome damage, they 
cannot detect mutagenic compounds that cause microlesions in the DNA. 
Moreover, chromosomal aberrations in these assays may not be the result 
of direct action of the test compound on the chromosomes. Thus, 
interpretation of the data is difficult (22). 
Another in vivo short-term assay used to detect chromosome 
damage is the micronucleus test (22). Reticulocytes or polychromatic 
erythrocytes from bone marrow are removed from animals treated with the 
test substance and then scored for chromosomal fragments in the 
cytoplasm of interphase cells. An increase in the number of 
micronuclei in experimental animals over controls suggest that the 
substance causes genetic damage. The test is simple, but like with the 
cytogenetic assays, interpretation of the data is difficult. While the 
presence of micronuclei does suggest genetic damage, such chromosome 
aberrations may not necessarily be a direct result of treatment with 
the test substance (22). 
Sister chromatid exchange (SCE) measures the number of crossovers 
between sister chromatids which occur after chemical exposure. SCE 
protocols detect the ability of a compound to induce DNA rearrange-
ments, presumably toward the goal of repair. These exchanges 
apparently result from chromatid breakage and subsequent reunion. The 
significance of SCE is poorly understood. Apparently, the greater the 
DNA damage, the higher the frequency of cross-overs (repairs). 
Mutagens not causing DNA breakage may not be observed with this assay, 
placing great doubt on negative results for a test substance when the 
mechanism of action of the mutagen is unknown (22). 
Germ Cell Assays. Many germ cell assays for detecting 
mutagenesis in vivo by way of chromosomal aberrations have been 
developed. These include the dominant lethal assay, heritable 
translocation assay, and sperm morphology assay (see 19, 22 for 
review). 
The dominant lethal assay measures the number of living and dead 
embryos in mouse uteri following mating with a male treated with the 
14 
test substance. An increase in dead implantations is indicative of 
induced dominant lethal mutations in the sperm cells of the male. This 
assay has been reported to identify compounds that most likely cause 
chromosomal damage although lethality could possibly be due to single 
gene mutations (22). This assay has several other disadvantages. It 
is relatively insensitive due to spontaneous lethals. Moreover, the 
relevance of the test is questionable since dominant lethals cause no 
genetic threat to future generations (22), although there is concern 
for identifying substances that cause fetal loss in humans. 
The heritable translocation assay detects chromosome aberrations 
1.n the form of translocations which have occurred in the germ cells of 
the test organism. Usually male mice are exposed to a chemical and 
allowed to breed with a female. The male offspring are then placed 
with a female for mating. The female is killed 17 days after mating 
and the dead and live embryos are scored. An increase in dead embryos 
in treated over control groups suggests a mutational event. The 
presence of a translocation in the male germ cells is verified by 
cytogenetics. This test has the advantage of being more sensitive than 
the dominant lethal assay and detects heritable genetic defects (22). 
However, small mutations in the DNA may go undetected if they do not 
affect fertility. In addition, the test requires 10 weeks and the 
cytogenetics involved requires special skill (22). 
The sperm morphology assay detects the mutagenic capabilities of a 
compound in the sperm cells of male mice treated with the test compound 
for 2-10 weeks. The number of abnormal sperm is recorded. While the 
test is simple with sensitivity approaching that of the Ames test in 
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detecting mutagens (22), changes in sperm morphology are not 
necessarily due to genetic damage (22). 
DNA Repair Assays 
DNA repair assays include SCE and unscheduled DNA synthesis (UDS) 
tests. SCE assays have already been described as a somatic cell 
technique for detecting chromosome damage. UDS assays measure the 
synthesis of DNA in nondividing confluent monocultures after chemical 
exposure. The amount of tritiated thymidine incorporated into DNA is 
measured by autoradiography. UDS repair assays are burdened with 
technical difficulties since numerous controls are required to 
distinguish UDS from spurious repair (19). 
Cell Transformation Assays 
There are many cell transformation assays which measure the 
ability of a substance to oncogenically transform a mammalian cell line 
(see 23 for review). Hamster, mouse, rat, and human cell lines have 
been used. However, while most of these assays show promise as good 
methods for identifying carcinogens, a great deal of work must be done 
before these assays will be of practical use (23). Many carcinogenic 
chemicals are not metabolized to their active intermediates by cells in 
culture. Standardization of cell lines is also a problem because the 
frequency of spontaneous transformation varies. Moreover, the 
identification of transformed cells tends to be subjective since it is 
often based on the morphological appearance of the cells. This 
demonstrates the need for the development of biochemical markers as 
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indicators of transformation (23). In addition, cell culture systems 
are difficult and expensive to maintain. 
The Need For the Development of Additional 
Short-term Genotoxicity ~ssays 
All short-term genotoxicity assays have serious limitations. 
However, when assessing the toxicity of a chemical, these limitations 
can be minimized when a battery of tests are used (8). All of the 
short-term genotoxicity discussed were designed to identify only 
mutagenic agents .• These tests were not designed to identify compounds 
which affect gene expression by nonmutagenic DNA damage or through 
alterations in RNA or protein synthesis. Furthermore, present 
genotoxicity assays cannot link the molecular events involved in gene 
expression to the embryonic development of the organism. It is known 
that environmental agents can cause either congenital or nonheriditary 
malformations in development. Such substances are called teratogens. 
The correlation between the teratogenic and mutagenic effect of 
chemicals in mammals has been known for many years (24). However, 
tests which attempt to define a biochemical basis of teratogenicity 
through changes in gene expression or DNA damage using a single 
organism have yet to be developed. 
The Development of Xenopus laevis 
as a Test Organism 
It has been stated that Drosophila melanogaster is the 
best genetically characterized and standardized test organism with the 
17 
house mouse ranking a distant second (22). However, Xenopus 
laevis, the South African Clawed Frog, ranks highly when compared 
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to both of these organisms with regard to the level of characterization 
of gene organization, gene expression, growth and development. The 
stages of morphological events associated with the development of 
Xenopus from the fertilized egg through metamorphosis have been 
well documented (25). The changes in the synthesis of the various 
classes of nucleic acids during oogenesis, fertilization, and early 
development in the frog embryo have been determined (26). Dumont has 
characterized the stages of Xenopus oocyte development, from the 
immature follicle to the mature cell (27). Xenopus oocytes can be 
surgically removed by the hundreds without the death of the animals and 
the oocytes survive for at least 48 hours in simple salt solutions 
(28). The frogs are commercially available from many vendors and are 
easily and inexpensively maintained in the laboratory. It seems then, 
that Xenopus may be an excellent organism for toxicity testing. 
The potential of using Xenopus embryos for toxicity testing 
was recognized by several investigators but most notably by Greenhouse 
(29-31). Dumont and coworkers later standardized and validated the use 
of Xenopus embryos in a true teratogenicity assay and named this 
system FETAX (Frog Embryo Teratogenesis Assay, Xenopus) (5-7). 
Dumont suggested the use of the teratogenicity index (LC50/EC50 
malformation) as a numerical representation of the teratogenic 
potential of a substance; the larger the teratogenicity index (TI), the 
more potent the teratogen (7). The TI may provide a method of 
extrapolating toxicity data collected for the amphibian to other 
species, including mammals. However, differences in species 
sensitivity to test compounds may cause large variations in 
teratogenicity indices. Nonetheless, a compound with a high TI for 
several species is more likely to be teratogenic to man than substances 
which possess a low TI in different organisms since in the latter case 
the incidence of malformation would be less. 
The effect of various inhibitors of DNA, RNA, and protein 
synthesis on development has been investigated (see 32 for review). 
Agents which inhibit DNA synthesis, such as chemotheraputic compounds, 
are potent teratogens, although the mechanism of teratogenesis may be 
through cell death rather than through the actual inhibition of DNA 
synthesis itself, (32). RNA synthesis inhibitors such as actinomycin D 
have also been associated with teratogenesis (32). However, in 
contrast to DNA and RNA synthesis inhibitors, inhibitors of protein 
synthesis do not appear to be teratogenic but are certainly cytotoxic 
(32). This suggests that protein synthesis inhibitors are not specific 
for a particular cell type (32) unlike what may be the case for DNA and 
RNA synthesis inhibitors. 
The oocyte offers a unique advantage as a molecular system for 
studying the effects of toxins at the level of the gene because the 
oocyte represents a cell destined after fertilization to divide and 
differentiate into an embryo. This permits the effect of a test 
substance on the gene in the Xenopus oocyte to be compared to the 
effect of the test agent on the development of the Xenopus embryo 
as determined by teratogenicity testing. While Xenopus embryos 
have been previously employed in toxicity tests (5-7), Xenopus 
oocytes have not. However, the Xenopus oocyte is well known for 
its ability to transcribe foreign genes which have been microinjected 
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into the nucleus and translate foreign mRNAs. Thus, it seemed possible 
to design a toxicity assay to study the effect of chemicals on the 
expression of a particular gene in the Xenopus oocyte. The 
characteristics of the oocyte which enable its use in a toxicity assay 
will now be discussed. 
The Xenopus Oocyte 
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The Xenopus oocyte is a very large cell at maturity (stage 6), 
being 1-1.2 mm in diameter with a 0.4 mm nucleus (germinal vesicle) 
(27). The oocyte nucleus is not only remarkable for its size but for 
its rate of hnRNA and rRNA synthesis as well. It has been estimated 
that hnRNA is transcribed with an average frequency two to three times 
greater in the oocyte than the rate normally found in animal cells 
(33). During oogenesis, each oocyte accumulates massive amounts of 
diverse mRNA species (34-35). The accumulation of mRNA in the oocyte 
occurs early in oogenesis and does not occur thereafter (36-37). 
However, transcription of single copy genes by RNA polymerase II has 
been demonstrated in full grown oocytes (see 38 for review). Estimates 
on the rate of mRNA synthesis suggest that this may be due to the rapid 
production and degradation of mRNA by mature oocytes (33, 39). The 
possibility that mature oocytes are deficient in some mechanism of mRNA 
processing seems unlikely since mature oocytes have been demonstrated 
to be fully capable of several post-transcriptional activities (40). 
By maturity, an oocyte contains great reserves of RNA and proteins 
required for embryogenesis. To assure successful development following 
fertilization the oocyte contains a store of ribosomal 48 and SS RNAs 
\ 
(41), RNA and DNA polymerases (42-43), histones (44), and nucleoprotein 
assembly' complexes (45-46). 
The Uses of the Xenopus Oocyte in 
Microinjection Studies 
The Oocyte as a Method for Studying Gene Expression 
In 1971, Gurdon and coworkers injected mRNA into the cytoplasm of 
the Xenopus oocyte and found that the oocyte translated this 
message into protein (47-48). Over the past ten years not only mRNA 
but cloned and purified genes as well as organelles have been injected 
into amphibian eggs and oocytes (see 49 for review). Xenopus 
oocytes represent a living cell which can be used to study purified 
macromolecules. Xenopus oocytes are extensively used to study 
different aspects of gene regulation including DNA template 
requirements, polyadenylation, RNA splicing, base modification, order 
of RNA processing, partitioning of RNA molecules between the nucleus 
and the cytoplasm, and post-translational modifications (50). 
Microinjection of mRNA Into Xenopus Oocytes 
A great deal of information regarding translation has come from 
mRNA injection studies with Xenopus oocytes. The frog oocyte 
translates, with varying efficiency, a wide variety of mRNAs from 
different species and phyla including insects, birds, mammals, viruses, 
plants, and fishes (see 51-53 for review). It is generally agreed that 
the translational machinery of the Xenopus oocyte is neither cell 
type (54), species (48), nor phylum specific (55) since heterologous 
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messengers (mRNAs other than those of Xenopus origin) are 
translated. However, Lane (52) has pointed out that this conclusion 
must be held with caution since most of the mRNA injection experiments 
used crude mRNA preparations that may have contained species-specific 
factors which permitted translation. Nonetheless, experiments have 
shown that all messengers use at least some common translational 
machinery since competition occurs between different injected 
messengers (56) as well as between endogenous (oocyte) and injected 
messengers (57) in oocytes. While the oocyte seems to translate any 
authentic eukaryotic mRNA (see 52 for review), other mRNAs such as 
synthetic polynucleotides (58) and bacteriophage mRNA (47, 53) are 
inactive. There is evidence that a 7-methylguanosine cap is required 
for translation since removal of the cap from globin mRNA (59) 
dramatically reduces translation while the addition of a cap to a 
prokaryotic messenger permits its translation in a eukaryotic system 
(60). It has been suggested that the role of the cap is to protect the 
mRNA from degradation (53). However, it is unknown whether many of the 
mRNAs translated in oocytes actually possess a 5' terminal cap or not 
(49) since many of these reports have not examined the mRNA termini. 
The literature suggests that at least one protein, ovalbumin, is 
apparently transcribed and translated from genes which are deficient 1n 
cap site sequences (61). 
The role of the poly(A) segment on eukaryotic messengers has been 
investigated using Xenopus oocytes. In the case of SV40 RNA it has 
been shown that only adenylated molecules are able to leave the nucleus 
of the oocyte (40). This does not appear to be true for all 
transcripts injected into nuclei since the messengers of histone and 
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the thymidine kinase genes are largely deficient in poly(A) but are 
translated anyway (62, S. L. McKnight, personal communication to 49). 
The poly(A) segment has been suggested to play a role in the stability 
of mRNA molecules in the cytoplasm since some deadenylated mRNAs, for 
example, globin mRNA, are less stable in Xenopus oocytes than 
adenylated molecules (see 53 for review). However, not all 
deadenylated mRNAs appear to be less stable in Xenopus oocytes than 
adenylated transcripts (63-64). On the basis of this information, it 
is possible that the poly(A) segment may function differently for 
different mRNA species. 
Translation in the oocyte is not regulated by the supply of mRNA 
(57) as believed in early studies (65). Therefore, oocytes do not have 
spare translational capacity since endogenous and injected messengers 
compete for a limited translational activity (57). The limiting factor 
appears to be some component of the translational apparatus (56-57). 
Xenopus oocytes are also capable of performing post-
translational modifications on many foreign proteins (see 52 for 
review). These modifications include phosphorylation, hydroxylation, 
glycosylation, acetylation, signal sequence removal, and disulfide bond 
formation of proteins from a diverse group of organisms including 
viruses, fishes, insects, amphibians, birds, and mammals (52). This 
demonstrates that frog enzymes can process foreign proteins which 
suggests that these enzymes are not species or cell-type specific. 
Injection of Purified DNA and Cloned Genes 
Replication in Oocytes and Unfertilized Eggs. As a logical 
extension of mRNA injection experiments, DNA was injected into 
Xenopus oocytes and unfertilized eggs. Initial experiments were 
designed to study gene replication. Purified DNA was replicated when 
injected into the cytoplasm of unfertilized eggs (66). The mechanism 
of replication in unfertilized eggs appeared to follow the 
semiconservative model (67-69). DNA was not replicated when injected 
in the cytoplasm of oocytes (46, 70-73). When DNA was injected into the 
nucleus of oocytes, replication occurred only at very low levels (71) 
or not at all (67). Because DNA is not significantly replicated in 
oocytes (67, 71), the expression of DNA introduced into Xenopus 
nuclei reflects the actual number of genes microinjected into the cells 
(74). 
When one considers the changes which occur in the synthesis of 
various nucleic acids during oogenesis, fertilization, and early 
development of Xenopus, it is hardly surprising that microinjected 
DNA will be replicated in unfertilized eggs but will not be replicated 
in oocytes. DNA synthesis in Xenopus oocytes occurs only at low 
levels while RNA synthesis proceeds at very high levels. In the case 
of unfertilized eggs, where cleavage is stimulated artificially by 
injection (75), DNA synthesis becomes quite active following germinal 
vesicle breakdown while RNA synthesis is negligible until the late 
blastula or early gastrula stage (26). Because oocytes will synthesize 
greater amounts of RNA and protein and are generally more tolerable to 
microinjection (49), they are routinely selected for the injection of 
purified DNA and cloned genes. 
Transcription in Oocytes. The first indication that pure DNA 
may be transcribed in Xenopus oocytes came from the work of Colman 
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who demonstrated that the synthetic nucleotide poly d(AT) stimulated 
RNA synthesis (76). In 1977, Mertz and Gurdon reported that SV40 DNA 
was transcribed in Xenopus oocytes (77) while Brown and Gurdon 
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showed that purified Xenopus SS RNA was faithfully transcribed in 
oocytes as well (78). In that same year, DeRobertis and Mertz 
demonstrated that some of the mRNA synthesized after injection of SV40 
DNA was translated (79). This was the first report of coupled 
transcription-translation in the oocyte. At present, numerous purified 
and cloned genes .have been transcribed in frog oocytes by the correct 
RNA polymerase from plasmid, phage, viral, plant, and animal sources 
(see 52 for review). 
Fate of Injected DNA. Xenopus oocytes will transcribe 
genes injected directly into the nuclei but not the cytoplasm (77, 80). 
Microinjection of Xenopus oocytes into the germinal vesicle was 
first developed by Gurdon (66) but later modified by Kressmann (80) to 
permit visualization of the nucleus. When DNA is injected into oocyte 
nuclei it does not appear to be integrated into Xenopus chromosomes 
(75) and so there is no direct influence of the host cell genes on the 
expression of the foreign nucleic acid (75). This permits the effect 
of a test substance on the expression of one particular gene (the gene 
mifroinjected) to be determined. 
The amount of DNA injected into oocytes dictates the amount of 
protein (81) or RNA (82) transcribed in oocytes. This suggests that 
injected genes are transcribed independently of. one another since large 
amounts of microinjected DNA does not compete out endogenous 
transcription (82). However, competition between different injected 
messengers (56) for translation does exist. Thus, it appears that 
there may be spare transcriptional activity but not spare translational 
activity (57) in oocytes. 
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The Importance of Template Topology. The transcription of 
injected DNA molecules is influenced by the conformation of the 
template (see 49 for review, 72, 83-84). Circular conformations of DNA 
are degraded in the cytoplasm (49) but are stable in the nucleus (49). 
Linear DNA templates are degraded in both the nucleus and the cytoplasm 
(49). The transcriptional inefficiency of linear templates in the 
nucleus cannot be due to degradation alone (84). The inefficiency of 
the protein-coding linear RNA polymerase II templates is far greater 
than what is observed for linear RNA polymerase III templates (84) 
which transcribe tRNA and SS RNA genes. Linear molecules carrying tRNA 
(80) or SS RNA (82) are transcribed only slightly less efficiently than 
circular templates. However, circular templates are preferred, and 
there is evidence that the template must be double-stranded for 
transcription, at least in the case of tRNA genes (85). Circular 
double-stranded DNA templates injected into the nuclei are assembled 
into nucleoprotein complexes (84, 86) and appear as beaded chains like 
cellular chromatin (86). Circular DNA injected into the nuclei of frog 
oocytes is initially relaxed then supercoiled (86). Linear DNA is not 
assembled into chromatin in oocytes (84). Nucleoprotein complexes of 
injected circular DNA molecules have been visualized with the electron 
microscope (87-88). Even mitochondrial DNA, which in nature is not 
associated with histone and nuclear transcriptional complexes, forms 
nucleosome like structures when injected into Xenopus oocytes (73). 
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The bulk of injected circular DNA templates may be transcriptionally 
inert (88-89), which is supported by the low transcription of 
heterologous RNA polymerase II genes in Xenopus oocytes (see 49 for 
review). The overall process by which injected DNA is expressed in the 
frog oocyte is illustrated in Figure 1. 
Transcription of RNA Polymerase III Genes. The best studied 
of the genes microinjected in Xenopus oocytes have been those genes 
coding for various tRNAs which are transcribed by RNA polymerase III 
(90-91). In 1977, Kressmann et. al (80) found that 48 RNA was 
synthesized by oocytes injected with Xenopus tDNA t" Later it 
me 
was shown that this tRNA t from Xenopus was fully processed and 
me 
modified after injection (92). Heterologous tDNAs, including nematode 
(93) and yeast tyrosine tRNA genes (90, 94), are also transcribed in 
Xenopus oocytes. It is now believed that Xenopus oocytes will 
transcribe eukaryotic nuclear tRNA genes but neither prokaryotic nor 
mitochondrial tRNA genes (91). 
Frog oocytes microinjected with tRNA genes have been used to 
analyze RNA processing steps in eukaryotes. tRNA genes injected into 
Xenopus oocytes undergo post-transcriptional removal of the 5' 
leader sequence (91), base modifications, addition of the 3' terminal 
CCA end, splicing of intervening sequences (90, 94), and excision of 
extra 3' and 5 1 nucleotides (94). These modifications appear to occur 
in the nucleus rather than in the cytoplasm (91). The splicing enzymes 
required for removal of intervening sequences are found in the nucleus 
(91, 95) and not in the nuclear membrane (95). Only mature tRNA 
molecules leave the nucleus (91). 
Figure 1. Microinjection of the Xenopus oocyte. This figure 
illustrates the steps involved in the expression of an injected 
protein-coding gene in the frog oocyte. This figure was modified from 
an illustration which appeared in Gurdon and Melton (49). 
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The sequence requirements of RNA polymerase III in oocytes have 
been studied. The promoter region on the Xenopus tRNA gene 
met 
has been investigated (96-99). A tRNA gene of Xenopus laevis 
requires at least two sites for transcription (97-99). These regions 
are highly conserved in both prokaryotic and eukaryotic tRNAs (99). 
SS RNA genes (transcribed by RNA polymerase III) have also been 
studied in Xenopus oocytes (78, 82, 87, 100). These include 
injected purified or cloned SS DNA from Xenopus (78, 82) as well as 
heterologous sources such as the water beetle (100). The transcription 
of cloned Xenopus (87) and water beetle (100) ribosomal genes has 
been visualized with the electron microscope. 
Transcription of RNA Polymerase II Genes. Transcription of 
protein-coding genes injected into Xenopus oocytes is under the 
control of RNA polymerase II (62, 101-102). This is also true for the 
transcription of messengers for endogenous proteins. Many proteins 
have been synthesized in oocytes injected with either purified DNA or 
cloned genes derived from various sources including SV40 (40, 79, 103), 
polyoma (103), adenovirus (81), herpes thymidine kinase (102-104), 
Drosophila heat shock (105) and histones (79), sea urchin histones 
(62, 106), and chick ovalbumin (61). Further evidence of transcription 
of heterologous DNA in injected oocytes has been obtained from studies 
where the presence of foreign mRNA molecules rather than the 
identification of the protein product was determined such as in the 
case of SV40 DNA (40, 50, 77), adenovirus DNA, ColEl plasmid DNA, 
bacteriophages ~Xl74 and ~80piac DNA, cloned Drosophila histone 
genes (77), sea urchin histone genes (107-109), and the herpes 
thymidine kinase gene (110). mRNAs with proper 3' and S' termini have 
been found in oocytes injected with cloned histone genes (109) and 
adenovirus transcripts (81). In addition, Xenopus oocytes can 
synthesize and process SV40 transcripts including cleavage at 3' splice 
sites, formation of 3 1 terminus, addition of a poly(A) tail, and 
selective intracellular partitioning such that only those messengers 
with a mature 3' terminus and poly(A) tail are found in the cytoplasm 
(40). Splicing is not correlated with the partitioning of SV40 
transcripts 1n the nucleus (40). Xenopus oocytes process the 
transcripts of injected genes spliced both inside (103-SV40 large T, 
polyoma middle T; 61-chick ovalbumin) and outside (103-SV40, polyoma 
capsid protein genes) of the protein coding region as well as genes 
which are not spliced at all (79-Drosophila histone; 62, 106-sea 
urchin histone; 102-104-herpes thymidine kinase; 81-E2A gene of 
adenovirus). 
Transcriptional Efficienc_1 of the RNA Polymerase.!_! and 
III Genes in Xenopus Oocytes. The transcriptional efficiency of 
genes injected into Xenopus oocytes is lower for the RNA polymerase 
II genes than for the RNA polymerase III genes as determined by 
transcriptional rates (see 49 for review). While nematode tRNA 1s 
transcribed at a frequency of 27 transcripts/gene/hour (tr/g/hr) (91), 
Xenopus tDNA, 50 tr/g/hr (92), and Xenopus 58 RNA, 25 tr/g/hr 
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(82), the sea urchin histone gene is transcribed at a comparatively low 
frequency, 0.1 tr/g/hr (77), as is herpes thymidine kinase, 0.15 
g/tr/hr (110). The transcription rate for SV40 DNA and chick ovalbumin 
is less than 0.1 tr/g/hr (61, 79). The reason for RNA polymerase III 
genes are transcribed more efficiently than RNA polymerase II genes in 
Xenopus oocytes is unknown. 
Transcriptional Fidelity of the RNA Polymerase.!.! and 
III Genes in Xenopus Oocytes. While there is ample evidence for 
the coupled transcription-translation of RNA polymerase II genes, the 
degree of transcriptional fidelity may be limited, unlike the RNA 
polymerase III genes (109). The transcription of the ovalbum.in gene 
has been visualized and there is an extremely low frequency of 
reqularly transcribed genes in oocytes (88). While Wickens et. al (61) 
reported that chick ovalbum.in protein is synthesized in oocytes 
injected with the complete ovalbum.in gene, an incomplete ovalbum.in gene 
that lacks the l,eader sequence, cap site, TATA region, and 5' flanking 
sequences directs the synthesis of ovalbumin with the same efficiency. 
This raises the possibility that the normal production of functional 
mRNA from some genes does not require initiation at a precise sequence 
(61). However, this seems unlikely for all RNA polymerase II genes 
since the expression of many protein-coding genes is dependent on 
specific regions of the DNA serving as transcriptional control signals 
as has been shown for adenovirus E2A (81), herpes thymidine kinase 
(104), and sea urchin H2A histone (107-108). In addition, the oocyte 
do.es transcribe all five sea urchin histone genes with correct RNA 
termini, albeit with large differences in the efficiences (109). 
Therefore, the poor transcriptional fidelity of the ovalbum.in gene in 
Xenopus oocytes does not seem to be characteristic of all RNA 
polymerase II genes. 
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Some Genes Are Not Transcribed or Are Erroneously 
Transcribed in Xenopus Oocytes. Not all genes are transcribed in 
Xenopus oocytes. These include the L2-L5 protein coding genes of 
adenovirus (81), HI and H4 sea urchin histone genes (62), and 
prokaryotic or mitochondrial tRNA genes (91). This implies that there 
is some transcriptional deficiency in these injected genes. This 
appears likely for the HI and H4 genes of the sea urchin since these 
genes lack well defined TATAAATA and cap sequences upstream from the 
structural region (109). 
Some sea urchin histone DNA is erroneously transcribed from the 
antisense strand in oocytes (62). The extent to which injected DNAs 
are transcribed from the correct coding strand has been reviewed (49). 
Transcripts are not synthesized from the noncoding strand of 5S (82), 
oX174 (77), or thymidine kinase genes (S.L. Mcknight, personal 
communication to 49) but are synthesized from the noncoding strand of 
injected histone (62) and ovalbumin genes (61). While genes 
transcribed by RNA polymerase III are apparantly specific for the 
coding strand, RNA polymerase II. genes appear to vary in strand 
specificity (49). There is some evidence to suggest that erroneous 
transcripts of the noncoding strand are sequestered in the nucleus as 
in the case of sea urchin histone genes (62). This observation is 
supported by an additional report which demonstrated that incorrect or 
incomplete SV40 RNA transcripts also did not reach the cytoplasm (40). 
The Regulatorl Sequences of RNA Polymerase_!.! Genes 
Injected Into Oocytes. The regulatory sequences of protein-coding 
genes have been studied in the case of the sea urchin H2A histone gene 
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(107-108) and the herpes thymidine kinase (TK) gene (104, 111-112). 
The control region of the H2A histone gene can be functionally 
separated into three DNA segments (108). Deletion of the TATA box in 
the H2A gene does not abolish transcription but serves to create 
transcripts with different 5' ends and so may serve as a specificity 
element for a start signal (107). Transcription of the TK gene 
involves at least three distinct DNA sequence signals as well, all 
within 105 nucleotides upstream from the mRNA cap site (Ill). 
The Herpes Thymidine Kinase Gene 
The herpes TK gene is a particularly useful segment of DNA to 
microinject into Xenopus oocytes for gene regulation studies and 
because of this it can be used in Xenopus oocytes as a marker gene 
to measure the genotoxic potential of a test substance. Besides the 
fact that the herpes TK gene is transcribed and translated in the 
oocyte (102, 104) with reasonable efficiency (104), a great deal of 
information is known regarding the sequence and regulation of the gene 
itself. The gene has been completely sequenced and the coding regions 
defined (113-114). The gene does not contain intervening sequences 
(113-114) and the orientation of transcription has been determined 
(115). The molecular weight of the enzyme is 40-45,000 as determined 
by SDS gel electrophoresis (116-117). Knowledge regarding the 
substrate specificity of the herpes TK enzyme has permitted the 
detection of the enzyme in sensitive and specific assays (118-119) 
which are able to differentiate viral and endogenous TK (118). In 
addition, the TK enzyme, which catalyzes the phosphorylation of 
deoxythymidine to 5' deoxythymidine monophosphate, can be detected by a 
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simple assay which measures the amount of tritiated deoxythymidine 
phosphorylated in yitro. 
The herpes TK gene has also been microinjected and transcribed in 
other cell types besides frog oocytes including mouse eggs (120) and 
mouse somatic cells (121-122) as a method of studying gene regulation. 
In addition, the herpes TK gene can transform TK- cells to the TK+ 
phenotype (123-130) including humap cells (124), mouse L cells (125, 
127-129) and teratocarcinoma cells (130). This demonstrates that the 
herpes TK gene can function in other high eukaryotic cell types besides 
the frog oocyte. The idea of using the TK gene to measure the 
mutagenic capabilities of test substances is not new since the gene has 
previously been used in mutation studies in mouse lymphoma L5178Y cells 
(19, 20). Therefore, it seems that the TK gene injected into frog 
oocytes could be used to detect not only the mutagenic capabilities of 
a test substance but how a test compound affects the various steps 
involved in gene expression as well. Because the TK gene has been 
I 
demonstrated to function in many different cell types, including human 
cells, the regulatory mechanisms involved in gene expression of the TK 
gene in the frog oocyte assay can be extrapolated to mammalian 
organisms. It is also important to note that the frog oocyte assay 
system for genotoxicity is not limited solely to the use of the TK 
gene. Any cloned or purified gene could theoretically be used. 
However, the TK gene offers the advantage of being extensively studied 
in regard to the regulatory mechanisms governing its expression and the 
gene is commercially available from Bethesda Research Laboratories. 
The potential of using the oocyte to examine the effects of a test 
compound on several different genes whose regulatory mechanisms are 
36 
understood may provide a means of comparing the effects of test 
compounds on genes that may be regulated differently from one another. 
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ABSTRACT 
We have developed a short-term genotoxicity assay involving the 
microinjection of the cloned herpes thymidine kinase (TK) gene into 
Xenopus oocytes. The ability of the test substance to affect the 
expression of the TK gene was determined in two assays: the Gene 
Exposure Assay and the Oocyte Exposure Assay. The Gene Exposure Assay 
measures the ability of a test agent to bind or possibly fragment the 
plasmid DNA and thereby prevent the expression of the TK gene. The 
Oocyte Exposure Assay measures the ability of a test substance to 
affect the expression of the TK gene at any level. In order to 
validate these two assays, we have tested the effect of known 
inhibitors of DNA, RNA, and protein synthesis on TK expression in 
microinjected oocytes using concentrations close to the 96 h LC50 
values obtained during the teratogenicity testing of these substances. 
In the Gene Exposure Assay, actinomycin D gave positive results in that 
it completely inhibited TK production in oocytes. Hydroxyurea, 
cytosine arabinoside, cycloheximide, and ethidium bromide yielded 
negative results since these inhibitors did not prevent the synthesis 
of TK in oocytes. In the Oocyte Exposure Assay, actinomycin D and 
cycloheximide inhibited TK production in the expected manner while 
hydroxyurea and cytosine arabinoside appeared to stimulate TK 
production. Ethidium bromide did not affect the synthesis of TK. The 
Gene Exposure Assay and Oocyte Exposure Assay identify agents which 
alter the expression of the herpes TK gene in frog oocytes. Since the 
genotoxic potential of teratogens can be tested, information regarding 
the biochemical basis of teratogenicity may be obtained using this 
system. 
Keywords: Xenopus, oocytes, genotoxicity, teratogenicity, 
thymidine kinase. 
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INTRODUCTION 
Normal development depends on the timely expression of genes and 
the precise replication of genetic information. Genotoxic agents that 
interfere with these fundamental processes may be teratogenic. 
Screening assays that measure the potential of a substance to act as 
both a genotoxin and a teratogen should provide a better assessment of 
the teratogenic risk of a compound than a teratogenicity assay alone. 
The term genotoxin in the traditional sense refers to substances that 
cause changes in the DNA either directly or indirectly (1) which may be 
mutagenic and ultimately carcinogenic to the organism (2). However, 
this definition may be somewhat incomplete. There are many steps 
involved in gene expression including transcription, processing, 
transport, and translation. At each of these levels of the processing 
pathway a substance could interrupt the normal flow of information from 
gene into product. Therefore, it may be more appropriate to define a 
genotoxin as a substance that interferes with the normal expression of 
a gene at any level. 
The purpose of this investigation was to develop a short-term 
assay to determine the effect of a test substance on gene expression in 
the Xenopus oocyte and to correlate the results of such studies to 
the ability of these compounds to act as teratogens during the 
development of the Xenopus embryo. The genotoxicity assay 
presented in this paper is not a gene mutation assay although it can 
identify substances that cause DNA damage which affects gene 
expression. 
The South African Clawed frog, Xenopus laevis, was chosen 
as a test organism for this assay. There were several reasons for our 
choice. The animals are easy and inexpensive to maintain in the 
laboratory, the teratogenic potential of substances can be assessed in 
a 96 h whole embryo bioassay, and the Xenopus oocyte is capable of 
expressing a wide variety of foreign eukaryotic genes which have been 
microinjected into the nucleus. The Xenopus oocyte is an ideal 
system to study the ability of genotoxic agents to affect the 
expression of a specific gene. Since the Xenopus ·oocyte can 
transcribe numerous heterologous genes, although with variable 
efficiency, the oocyte appears to possess regulatory components that 
are similar to those found in a diverse array of species (3). This 
makes the data regarding the effects of substances on the regulatory 
processes involved in gene expression in Xenopus extrapolatable to 
other species, including man. 
To validate the use of the Xenopus oocyte as an indicator of 
the genotoxic potential of a substance, we have exposed the herpes 
thymidine kinase (TK) ~ene to known inhibitors of DNA, RNA, and protein 
synthesis either before or after microinjection of the gene into the 
nucleus of the oocyte. We have tested the ability of hydroxyurea, 
cytosine arabinoside, ethidium bromide, actinomycin D, and 
cycloheximide to interrupt the expression of the TK gene either 
directly by DNA damage or indirectly through inhibition of RNA 
synthesis or translation. Although any well characterized gene could 
be used for this assay providing that it was utilized by the oocyte, 
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the herpes TK gene has previously been shown to be successfully 
transcribed and translated into functional protein in the Xenopus 
laevis oocyte (4, 5). Moreover, the gene is commercially available 
(Bethesda Research Laboratories) and therefore does not require 
propagation prior to microinjection. This saves considerable time. 
The results presented in this report show that the Xenopus oocyte 
has great promise as a short-term assay for identifying genotoxic 
substances in the environment and provides data which can be correlated 
to the results of the 96 h Xenopus whole embryo teratogenicity 
bioassay described in a separate report from this laboratory (6). 
Together, both the Xenopus teratogenicity and genotoxicity assays 
provide complementary evidence on the potential hazards of specific 
compounds and therefore serve as a useful biomonitoring method. 
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MATERIALS AND METHODS 
Preparation of Oocytes 
Xenopus laevis females were anaesthetized in MS 222 
(Cresent Research Chemicals®) at a concentration of 1.5 g/1 in 
dechlorinated tap water. Oocytes were removed according to the 
procedure described by Kressmann and Birnstiel (7). A 1 cm incision 
was made in the skin slightly off-center of the midventral line. Using 
aseptic technique, the peritoneum and the muscle tissue were cut and a 
small portion of the ovary was pulled out. The cluster of oocytes was 
removed using scissors and placed in a Petri dish in modified Barth's 
solution (MBS-H) containing 88 mM NaCl, 1 mM KCl, 2.4 mM NaHC0 3 , 
0.82 mM MgS04 , 0.33 mM Ca(N03) 2 , 0.41 mM CaC1 2 , 10 mM HEPES, 10 
mg/1 benzylpenicillin, 10 mg/1 streptomycin sulfate, pH 7.6 (8). The 
remaining ovary was then pushed back into the body cavity and the 
incision closed making sure that the skin was sutured separately from 
the muscle layer and peritoneum. 
Stage 6 oocytes (9) were manually separated from the ovarian 
tissue using watchmaker's forceps and incubated in MBS-H at 20°C for 
approximately 18 h prior to microinjection. To facilitate injection 
directly into the nucleus, the oocytes were aligned in a I mm 2 screen 
which had been attached with silicone sealant to the bottom of a 
polyethylene lined scintillation vial cap and centrifuged in a swinging 
bucket rotor at approximately 1000 x gave. for 30 min at 20°C. This 
procedure, developed by Kressman et al. (10) causes a displacement of 
the pigment such that a brown concentric ring marks the nucleus. 
Centrifugation of the oocytes does not significantly affect their 
transcriptional ability (11). 
Microinjection Apparatus 
A siliconized glass capillary tube was initially tapered to a 
point using a microelectrode puller. To obtain an injection needle 
with an orifice of 10-20 µm, needles were placed on a microscope stage 
and bumped against a flat surface while observing under lOX 
magnification. A calibrated ocular micrometer was used to measure the 
size of the orifice. After filling with plasmid DNA, the needle was 
attached to a 10 µl gas tight Hamilton® microsyringe using rigid 
walled tubing. The syringe and tubing were filled with light paraffin 
oil. A syringe pump was used to push the oil which in turn forced the 
contents of the needle into the oocytes at a rate of approximately 2.5 
nl/sec. The needle was held by a pin vise (Curtin Mathis Scientific®) 
connected to a mechanical microscope stage. This allowed the tip of 
the needle to be accurately guided into the oocytes during injection. 
A dissection microscope was used to observe the microinjection process. 
Gene Exposure and Oocyte Exposure Assays 
The ability of a compound to inhibit macromolecular synthesis 
directly through DNA damage or indirectly by some other inhibitory 
effect of gene expression was investigated by the use of two assays: 
the Gene Exposure Assay and the Oocyte Exposure Assay. In both tests 
the plasmid pHSV-106 (Bethesda Reasearch Laboratories®), which 
contains a 3.4 kb insert of the entire herpes thymidine kinase (TK) 
gene, was microinjected into Xenopus stage 6 oocytes. 
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For the Gene Exposure Assay, the pHSV-106 DNA was exposed in 
vitro to various concentrations of known inhibitors of 
macromolecular synthesis for 2 h prior to injection at 20-25°C in 
MBS-H. After this time, the DNA was separated from the test substance 
by gel filtration chromatography (See "Test Substances and Injection 
Solutions"), and injected into oocytes. After injection (25 nl of 0.15 
µg/µl pHSV-106 per oocyte), the oocytes were incubated in MBS-H at 
23°C for 18-24 h then processed for TK activity as described below. 
For the Oocyte Exposure Assay, pHSV106 was injected directly into 
the germinal vesicle (nucleus) of stage 6 oocytes (25 nl of 0.15 
µg/µl pHSV-106 per oocyte). The pHSV106 DNA was not exposed to the 
test substance prior to microinjection. The oocytes were then exposed 
to different concentrations of known inhibitors of DNA, RNA, and 
protein synthesis in MBS-H (10-20 oocytes/group, 3 groups/ concentra-
tion) at 23°C for 18-24 h. After this time, the oocytes were 
processed for TK activity. 
Determination of TK Activity 
Oocytes were processed for the determination of TK activity using 
a slight modification of the assay used by Brinster et al. (12). 
Oocytes were homogenized (10 µ1/oocyte) in 10 mM KCl, 2 mM MgC1 2 , 10 
mM Tris-HCl, pH 7.4, 1 mM ATP, 10 mM NaF, 50 mM e-aminocaproic acid. 
The homogenate was centrifuged at 15,000 x gave, 10 min, 0-4°C, in an 
HB-4 rotor (Sorvall®). 37.5 µl of the supernatant was combined with 
187.5 µ1 of the assay (A) buffer containing 150 mM Tris-HCl, pH 7.4, 
10 mM ATP, 10 mM MgC1 2 , 25 mM NaF, 10 mM ~-mercaptoethanol, 5 µCi 
3H-thymidine (ICN®). The mixture was then incubated for 4-5 hat 
37°C in 1.5 ml conical micro-test tubes. Every hour during the course 
of incubation, 30 µl samples were spotted on Whatman® DE-81 filters. 
The filters were then washed three times in 95% ethanol, 5 min per 
wash. The filters were dried and the radiation measured by liquid 
scintillation spectrometry using a toluene based cocktail containing 
4.0 g/1 PPO and 0.1 g/1 POPOP at 20% counting efficiency. This 
d h f 3 h 0 d 0 d 3 proce ure measures t e amount o H-t ymi ine converte to H-TMP. 
Determination of TK Activity in the Presence of Inhibitors 
To test for the possibility that the inhibitors used in this study 
may have changed the catalytic efficiency of the TK enzyme, 37.5 µl of 
the supernatant from control oocytes was added to each of several 187.5 
µl aliquots of A buffer in which all but one mixture contained a 
different inhibitor. The control oocytes used in these experiments 
were injected with pHSV-106 DNA and homogenized 18-24 h later. The 
amount of TK enzyme present in these oocytes is that which has been 
synthesized in the absence of inhibitory substances. The amount of 
3H-thymidine phosphorylated to 3H-TMP in the presence and absence 
of the inhibitors was determined every hour for 4-5 has described 
above. The concentrations selected for all inhibitors were in excess 
of the highest concentration required to see an effect in the Gene 
Exposure or Oocyte Exposure Assay. 
Test Substances and Injection Solutions 
For the Gene Exposure Assay, the inhibitor was resuspended as a 
concentrated stock in distilled water. In the case of cytosine 
arabinoside, the pH of the stock was adjusted to 7.6 with NaOH to 
prevent a large change in the pH of the injection solution. This was 
not necessary for all other inhibitors used in this study. The 
concentration of inhibitor which was selected in the Gene Exposure 
55 
56 
Assay was usually the highest concentration used in the Oocyte Exposure 
Assay to reduce the possiblity of a false negative. The inhibitor was 
added at the desired concentration to the plasmid DNA in 10 mM 
Tris-HCl, pH 7.4, 5 mM NaCl, 1 mM EDTA in a total volume of 400 µl. 
After 2 hat room temperature the inhibitor was removed from the DNA by 
gel filtration chromatography using G-100 Sephadex (Pharmacia®). The 
excluded fraction containing the DNA was collected in a 1 ml volume and 
concentrated by lyophilization. The DNA was resuspended in 10 mM 
Tris-HCl, pH 7.4, 5 mM NaCl, 1 mM EDTA, filtered through a 0.2 µm 
polycarbonate filter (Nucleopore®) and injected. 
In the Oocyte Exposure Assay, oocytes were also injected with 
pHSV-106 DNA in 10 mM Tris-HCl, pH 7.4, 5 mM NaCl, 1 mM EDTA. It is 
strongly advised that the solution be filtered as described above to 
prevent small particulates from clogging the needle orifice. 
Inhibitors were dissolved at various concentrations in MBS-H solution. 
In the case of cytosine arabinoside, the pH of the solution was 
adjusted with NaOH to 7.4-7.6. For all other inhibitors, it was 
unnecessary to adjust the pH of the solution which remained that of 
MBS-H. All inhibitors were purchased from the Sigma® Chemical 
Company. 
RESULTS 
DNA Synthesis Inhibitors 
The DNA synthesis inhibitors tested in this investigation were 
cytosine arabinoside, hydroxyurea, and ethidium bromide. Ethidium 
bromide is also an inhibitor of RNA synthesis. The results expected 
for the DNA synthesis inhibitors were dependent upon their mode of 
action. Figure 1 and Table I show that hydroxyurea, an inhibitor of 
ribonucleotide reductase, had no effect on the production of functional 
herpes TK enzyme when the plasmid containing the herpes TK gene was 
exposed to a 10 mg/ml concentration of the inhibitor prior to 
microinjection into Xenopus oocytes in the Gene Exposure Assay. 
Concentrations of hydroxyurea ranging from 0.25-2.0 mg/ml were tested 
in the Oocyte Exposure Assay in order to obtain dose-response type 
data. However, not even as high as 2.0 mg/ml hydroxyurea inhibited the 
expression of the TK gene in oocytes (Table II). This was despite the 
use of a concentration of hydroxyurea sufficient to kill 50% of the 
embryos in the FETAX bioassay (Table II). This demonstrates that 
hydroxyurea did not damage the plasmid DNA or affect RNA and protein 
synthesis directly in the oocytes. 
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Similar results were obtained for the antimetabolite cytosine 
arabinoside and ethidium bromide, a DNA intercalator. 6.0 mg/ml 
cytosine arabinoside and 0.2 mg/ml ethidium bromide did not inhibit the 
expression of the TK gene in the Gene Exposure Assay (Table I). 
Cytosine arabinoside appeared to stimulate the production of TK in the 
Gene Exposure Assay. Several different concentrations of cytosine 
arabinoside and ethidium bromide were tested in the Oocyte Exposure 
Assay ranging from 0.05-2.0 mg/ml for cytosine arabinoside and 
0.002-0.2 mg/ml for ethidium bromide. However, even the concentrations 
of these compounds closest to the LC50 of the FETAX bioassay (6), 2.0 
mg/ml cytosine arabinoside and 0.02 mg/ml ethidium bromide, failed to 
inhibit TK expression in the Oocyte Exposure Assay (Table II). These 
results suggest that these inhibitors primarily interfere with DNA 
synthesis, which is absent in the oocyte, and kill embryos by some 
general cytotoxicity mechanism other than the flow of genetic 
information into protein. 
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It is possible, as in the case of hydroxyurea, that both ethidium 
bromide and cytosine arabinoside stimulated TK activity in the Oocyte 
Exposure Assay (Table II) since the amount of activity in experimental 
groups were higher than control groups. The 2.0 mg/ml value reported 
on Table II for cytosine arabinoside was the only concentration among 
the ranges tested (0.05-2.0 mg/ml) where the amount of TI< activity was 
lower than that of the controls. Concentrations of cytosine 
arabinoside lower than 2.0 mg/ml stimulated TK activity 1.6 fold over 
controls (data not shown). To study this stimulatory effect further, 
the amount of endogenous TK activity was measured by placing uninjected 
oocytes in 10 mg/ml hydroxyurea and 2 mg/ml cytosine arabinoside in 
MBS-H for 18-24 h. In this experiment, TK synthesis was stimulated 1.7 
and 1.4 fold, respectively (data not shown). Thus, both endogenous and 
viral TK production appear to be stimulated by hydroxyurea and cytosine 
arabinoside. However, the standard error of the mean reported for 
cytosine arabinoside and ethidium bromide in Table II suggests that the 
differences in TK activity 1n the Oocyte Exposure Assay were not 
statistically significant. 
RNA Synthesis Inhibitors 
Ethidium bromide, and actinomycin D were selected as inhibitors of 
RNA synthesis. Since ethidium bromide also inhibits DNA synthesis, the 
effect of this substances on TK expression was discussed in the 
preceeding section. Actinomycin Dis also capable of preventing DNA 
synthesis but at much higher concentrations than are required to 
inhibit RNA synthesis. Therefore, the primary effect of actinomycin D 
1s to prevent RNA transcription, and this occurs by the intercalation 
of actinomycin D into DNA (13). 
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The ability of actinomycin D to bind to the DNA template and 
prevent RNA transcription was demonstrated 1n both the Gene Exposure 
Assay (Figure 2, Table I) and the Oocyte Exposure Assay (Figure 3, 
Table II). When the plasmid DNA was exposed prior to microinjection in 
the Gene Exposure Assay to 0.025 mg/ml actinomycin D, no thymidine 
kinase activity was observed (Figure 2, Table I). However, when the 
oocytes were exposed to different concentrations of actinomycin Din 
the incubation medium after injection in the Oocyte Exposure Assay, the 
amount of thymidine kinase activity observed varied in a dose-response 
manner (Figure 3). While 0.13 mg/ml actinomycin D completely prevented 
transcription of the TK gene, 0.059 mg/ml actinomycin D permitted 25% 
of the amount of TK activity found in controls and 0.013 mg/ml 
actinomycin D allowed 39% of the TK activity found in controls (Figure 
3, Table II). 
Protein Synthesis Inhibitors 
The ability of cycloheximide to inhibit protein synthesis in the 
Xenopus oocytes was investigated. Figure 4 and Table I show the 
results obtained for the inhibition of TK activity when the plasmid DNA 
was exposed to 2.8 x 10-3 mg/ml cycloheximide for 2 h then separated 
from the inhibitor prior to injection. This data also provides 
evidence that positive results in the Gene Exposure Assay, such as that 
found for actinomycin D (Figure 2, Table I), were not due to poor 
separation of the plasmid DNA from the inhibitor since cycloheximide 
caused no effect. 
Following microinjection of oocytes and incubation in 
concentrations of cycloheximide ranging from 1.4 x 10-5 mg/ml to 1.4 
-2 
x 10 mg/ml, the amount of TK activity observed decreased as the 
concentration of cycloheximide increased (Figure 5). While 1.4 x 
10-2 to 1.4 x 10-3 mg/ml cycloheximide completely abolished TK 
enzyme activity, 1.4 x 10-4 mg/ml and 1.4 x 10-5 mg/ml 
cycloheximide permitted approximately 22% and 35%, respectively, of the 
amount of TK activity produced by controls. Together Figures 4 and 5 
show that cycloheximide does not damage the DNA but rather acts at some 
other level of processing to prevent the expression of the TK gene. 
TK Activity in the Presence of Inhibitors 
The ability of cytosine arabinoside, hydroxyurea, ethidium 
bromide, actinomycin D, and cycloheximide to affect the catalytic 
efficiency of the TK enzyme was determined by placing various 
concentrations of each inhibitor separately into assay buffer which 
contained a portion of the supernatant of control oocytes. None of the 
inhibitors used in this study were able to increase or decrease the 
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amount of 3tt-thymidine converted to 3tt-TMP in the absence of 
inhibitor (Table III). Therefore, an increase in TK activity must be 
due to an increase in the amount of TK synthesized and not an 
enhancement of the catalytic efficiency of the enzyme in vitro. 
Similarly, a reduction in TK activity would be due to a decrease in the 
amount of TK synthesized and not due to enzyme inhibition. 
Summary of Results 
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A surmnary of the results for the inhibition of DNA, RNA, and 
protein synthesis in Xenopus oocytes by known inhibitors of 
macromolecular synthesis for both the Gene Exposure and Oocyte Exposure 
Assay is provided in Tables I and II. All inhibitors behaved according 
to their expected mode of inhibitory action except ethidium bromide. 
DISCUSSION 
The Development of Xenopus laevis Oocytes as a Genotoxicity 
Assay 
One possible method of performing this assay was to simply 
microinject radioactive precursors of DNA, RNA, and protein synthesis 
into Xenopus oocytes in order to identify agents which alter 
macromolecular synthesis. We intentionally avoided the use of 
radioactive precursors for such studies because of the possible changes 
in the endogenous pool size of the precursor which may occur during 
experimentation. When cells are exposed to toxic agents, changes in 
membrane permeabilty or compartmentation of the nonradioactive pools 
may change the amount of incorporation of radioisotopes into DNA, RNA, 
and protein. This requires measurement of the pool sizes of 
experimental versus control groups which is too time consuming for a 
screening assay. Differential leakage of 3H-leucine injected into 
Xenopus oocytes after exposure to benzo(a)pyrene compared to 
controls was observed in initial experiments in our laboratory. This 
resulted in an apparent stimulation in protein synthesis in the oocytes 
exposed to benzo(a)pyrene due to a change in the ratio of 
nonradioactive to radioactive leucine available for protein synthesis. 
In addition, the injection of radioisotopes does not permit the 
monitoring of agents that are capable of causing DNA damage. We 
therefore elected not to develop an assay based on the microinjection 
of radioisotopes. 
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We have developed an assay which utilizes the herpes thymidine 
kinase gene cloned into a bacterial plasmid to identify genotoxic 
substances acting at any level of gene expression. However, this assay 
will only identify substances that prevent the production of functional 
TK. enzyme. It is not a replacement for gene mutation assays. The 
system is capable of identifying agents which bind to or fragment the 
DNA only if they prevent the expression of the TK gene. Such 
substances need not necessarily be mutagens. It is important to 
realize, however, that the goal of this assay is different from gene 
mutation assays such as the Ames Test. Our goal was to develop an 
inexpensive, short-term assay that would identify genotoxic agents and 
provide insight on the molecular mechanisms of teratogenesis. 
In this assay, the TK gene containing plasmid must be 
microinjected directly into the nucleus of the frog oocyte in order for 
transcription to take place (14). The amount of viral TK produced was 
measured by comparing the amount of total TK activity as measured by 
h b ·1· f h h 3 h "d" tea i ity o t e oocyte omogenate to convert H-t ymi ine to 
3H-'IMP in injected versus noninjected groups. The level of 
endogenous TK activity is very low in oocytes (see Figure 1 for 
example), thus virtually all of the TK activity observed in injected 
oocytes was assumed to be due to viral TK., Furthermore, the work of 
McKnight et al. (5) using a substrate specific for herpes TK but not 
Xenopus TK (15), have shown that the TK activity observed after 
injection was indeed viral in origin. 
We have used the Xenopus oocyte to identify DNA binding agents 
which prevent transcription as described by the Gene Exposure Assay as 
well as compounds which prevent the expression of the herpes TK gene 
without necessarily causing DNA damage in an assay referred to as the 
Oocyte Exposure Assay. The importance of using both assays in the 
routine screening of the genotoxic potential of a substance is well 
demonstrated in the case of cycloheximide which does not damage DNA or 
prevent transcription (Figure 4) but does prevent the translation of 
RNA into protein (Figure 5). 
Rationale for Comparing the FETAX LCSO to Similar Test Concentra-
tions in the Genotoxicity Assay 
The 96 h LCSO of the Xenopus whole embryo (FETAX) bioassay (6) 
was used in performing the genotoxicity assay (Tables I and II) rather 
than the 96 h ECSO (malformation). Xenopus oocytes are more 
sensitive to toxicants than are early embryos. This difference in 
sensitivity made it impossible to state that any inhibition of gene 
expression in the oocyte at the 96 h ECSO (malformation) would 
definitely be a factor that caused malformation in the whole embryo 
test. However, if a test substance did not inhibit gene expression in 
oocytes at the embryo 96 h LCSO, then any malformation or toxicity 
observed in the FETAX test could not be due to genotoxicity since this 
concentration would surely inhibit gene expression in the more 
sensitive oocytes. Conversely, substances which inhibited TK synthesis 
I 
in oocytes would almost certainly affect protein synthesis in embryos, 
although the extent of inhibition may be less. 
The Effect of Inhibitors on Herpes TK Expression in the Oocyte 
The inhibitors used in this study were selected on the basis that 
their mode of action on DNA, RNA, or protein synthesis was known. For 
the validation of this assay, it is crucial to demonstrate that the 
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frog oocyte microinjected with the herpes TK gene will respond to such 
inhibitors in the expected manner. 
Most of the inhibitors used in this study behaved according to 
their known mode of action. The DNA synthesis inhibitors hydroxyurea 
and cytosine arabinoside were both negative in the Gene Exposure and 
Oocyte Exposure Assays in that they did not decrease the amount of TK 
enzyme produced. However, hydroxyurea and cytosine arabinoside may 
have increased TK production. Since hydroxyurea is known to inhibit 
ribonucleotide reductase which catalyzes the conversion of 
ribonucleotides to deoxyribonucleotides (16), and there is virtually no 
DNA synthesis in mature oocytes (17), a reduction in the transcription 
of the herpes TK gene or subsequent translation of the RNA into protein 
was not anticipated. It has been previously documented that while 
hydroxyurea inhibits DNA synthesis, RNA and protein synthesis continue 
(16, 18). This is also true for cytosine arabinoside (19) whose 
mechanism of action has been suggested to be the inhibition of the 
reduction of CDP to dCDP (20). 
The possibility that hydroxyurea and cytosine arabinoside may have 
stimulated the amount of TK normally expressed in injected oocytes 
(Table II) is supported by the literature. The same effect for these 
compounds was observed in cultured cells at concentrations even lower 
or identical to the concentrations used in this study (18-19). Kim et 
al. (1967) found that 0.076 mg/ml hydroxyurea increased the amount of 
TK activity by three fold over controls in HeLa cells after 24 h (18). 
Kit et al. (1966) found that 0.05 mg/ml cytosine arabinoside stimulated 
the thymidine kinase activities of green monkey kidney and HeLa cells 
after 48 h by 5 and 10 fold, respectively, but not mouse lymphoma cells 
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(19). This increase in TK activity could be prevented by cycloheximide 
suggesting that this effect was caused by increased amounts of the TK 
protein production (19). Our data precludes the possibility that these 
inhibitors increase TK activity without increasing the amount of TK 
synthesized in Xenopus oocytes since hydroxyurea and cytosine 
arabinoside did not affect the activity of TK when placed in the assay 
buffer of control oocytes (Table III). However, our results do not 
show an increase in TK activity as high as was reported by Kim et al. 
(18) and Kit et al. (19) after 24 h incubation in hydroxyurea and 
cytosine arabinoside since 0.25 mg/ml hydroxyurea stimulated TK 
activity by 1.6 fold while 1.0-2.0 mg/ml hydroxyurea caused a 2.5 fold 
increase in TK activity. In the case of cytosine arabinoside, 0.05 
mg/ml also increased TK activity in microinjected oocytes by 1.6 fold 
over that of controls. The differences between our data and the 
results reported by other investigators (18-19) could easily be 
accounted for by an increase in sensitivity of cultured cells to these 
inhibitors due to several reasons. Cultured cells are typically active 
in DNA synthesis while Xenopus oocytes are not. Differences in 
species sensitivity may also be important. However, it may be possible 
that the stimulatory effect of hydroxyurea and cytosine arabinoside on 
TK production in microinjected oocytes may be due, at least in part, to 
variable amounts of RNA and protein synthesized from the injected 
template. This problem has been reported by investigators working with 
Xenopus oocytes (14, 21-22). We are presently performing 
additional experiments to evaluate this possibility. 
Our assay, as presently developed, cannot measure the effect of a 
test substance on replication. However, if the process of replication 
66 
had been assayed, both hydroxyurea and cytosine arabinoside should have 
had a significant inhibitory effect (16, 18-19). We are presently 
developing a replication assay using Xenopus oocytes. However, in 
the meantime, a rise in TK activity may indicate that a compound is 
inhibitory to DNA synthesis and that the cell has a larger amount of 
RNA than DNA precursors and therefore makes more RNA and protein than 
controls. The testing of additional inhibitors of DNA synthesis will 
determine whether this is a general response or specific to the 
inhibitors thus far tested. 
The response of Xenopus oocytes to ethidium bromide was 
different from that expected. In both the Gene Exposure (Table I) and 
Oocyte Exposure (Table II) assays, up to 0.2 mg/ml ethidium bromide did 
not inhibit TK activity. Ethidium bromide is well known for its 
ability to intercalate linear double-stranded DNA more readily than 
circular double-stranded DNA (23). Although it is likely that ethidium 
did intercalate into the circular double-stranded DNA molecule used in 
this study, this intercalation was not sufficient to prevent the access 
of RNA polymerase to the promoter regions of the TK gene. This result 
is probably related to the conformation of the plasmid DNA. Harland et 
al. (22) have suggested that the transcription signals of the herpes TK 
gene in Xenopus oocytes may function not only by the binding of 
regulatory proteins to sequence-specific regions on the DNA but by the 
conformation of the DNA as well. In addition, ethidium bromide was 
also only marginally teratogenic to Xenopus embryos (6). This 
suggests that ethidium may have also intercalated poorly into native 
chromatin which is protected by proteins. However, it remains unclear 
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as to whether the results obtained for ethidium bromide in both this 
assay and the teratogenicity assay (6) represent a false negative. 
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The RNA synthesis inhibitor, actinomycin D, was positive in both 
the Gene Exposure (Figure 2, Table I) and Oocyte Exposure (Figure 3, 
Table II) Assays. Since actinomycin Dis capable of intercalating into 
double-stranded DNA including native chromatin such results were 
anticipated (13). Moreover, the oocytes responded to actinomycin Din 
a dose-response manner. However, we have had difficulty in determining 
the range of concentration of a substance to use in order to obtain the 
higher limits of a dose-response curve because of two problems. First, 
the concentration range needed to elicit a response from 40 to 80% of 
controls tends to be narrow. Second, the amount of experimental 
variability in some cases is often high so that the standard errors of 
the mean from different concentrations overlap. We consider this 
variability our most difficult problem with the Oocyte Exposure Assay 
and are currently working on techniques to overcome this difficulty. 
Other investigators have also reported similar variability problems in 
the expression of microinjected genes in Xenopus oocytes (14, 
21-22) 
The results for the protein synthesis inhibitor, cycloheximide, 
were negative in the Gene Exposure Assay (Figure 4, Table I) but 
positive in the Oocyte Exposure Assay (Figure 5, Table II). Since 
cycloheximide is known to disrupt eukaryotic protein synthesis by 
preventing initiation and elongation, the inability of cycloheximide to 
bind or damage the DNA in the Gene Exposure Assay was expected. 
Increasing concentrations of cycloheximide also decreased the amount of 
functional TK enzyme produced, yielding dose-response type data with 
limitations as described for actinomycin D. 
Identifying the Molecular Causes of Teratogenicity 
The data of Courchesne and Bantle (6) as well as others (24) have 
shown that DNA synthesis inhibitors are highly teratogenic in diverse 
species while RNA and protein synthesis inhibitors are not. We are 
unable to link the results obtained in this study for the DNA synthesis 
inhibitors to the teratogenic activity of these substances since the 
process of replication could not be directly measured. However, we can 
compare the effects of the RNA and protein synthesis inhibitors on TK 
expression in Xenopus oocytes to their effects on the growth and 
development of Xenopus embryos. Doses of actinomycin D which 
caused a significant decrease in RNA synthesis in the oocyte were also 
lethal to the embryo. With whole embryo teratogenicity tests using 
-2 Xenopus, 1.89 X 10 mg/ml actinomycin D was sufficient to kill 
50 % of the organisms in 96 h. In the Oocyte Exposure Assay 1.33 x 
10-2 mg/ml actinomycin D was sufficient to reduce TK production by 
60%. Therefore it appears that while actinomycin Dis not highly 
teratogenic to the organism it is generally cytotoxic. It has 
previously been noted that cytotoxicity of actinomycin Din 
proliferating tissues may be due to an intolerable loss of RNA (25), 
However, it is reasonable to assume that factors other than RNA 
synthesis ultimately determine the susceptibiltiy of various cells to 
inhibition by actinomy.cin D (25). For example, the loss in RNA has 
been related to an increase in ribonuclease activity caused by 
actinomycin (26). In addition, doses of cycloheximide which caused a 
large decrease in protein synthesis were also lethal to the embryo. A 
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1.59 x 10-4 mg/ml concentration of cycloheximide was enough to kill 
50% of the Xenopus embryos in 96 hand reduce 80% of protein 
synthesis in the oocyte. Due to the differences in the time of 
exposure of oocytes (24 h) and embryos (96 h) it may be unwise to imply 
that a 60-80% decrease in RNA and protein synthesis in the embryo is 
required before lethality. However, the data imply that embryos may be 
able to survive in spite of significant decreases in RNA and protein 
synthesis by perhaps decreasing growth or the rate of development (6). 
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We have developed the Xenopus Genotoxicity Assay to be used 
together with, and not separately from, the Xenopus Teratogenicity 
system described in the proceeding paper (6). When both assays are 
used together, the possibilty that a biologically hazardous substance 
will escape detection is minimized. For example, the DNA synthesis 
inhibitors cytosine arabinoside and hydroxyurea gave negative results 
for both the Gene Exposure and Oocyte Exposure Assays due to the 
limitations of the oocyte system at this time to measure replicatory 
processes. However, teratogenicity testing of these compounds showed 
them to be potent teratogens. 
When analyzing unknown samples for teratogenicity and 
genotoxicity, the Xenopus teratogenicity (FETAX) assay (6) should 
be performed first. This procedure determines the 96 h LC50 and EC50 
malformation. It also measures the ability of the substance to inhibit 
growth. The 96 h LCSO concentration should then be used as the first 
concentration in measuring genotoxic effects using both the Gene 
Exposure Assay and Oocyte Exposure Assay. Our preliminary experiments 
suggested that oocytes were more sensitive to inhibitors than early 
stage embryos of ~enopus. Therefore, the selection of the 96 h 
LC50 should be adequate to elicit an effect in the oocytes. If the 
test substance does not cause a reduction in TK expression in oocytes 
at the 96 h LC 50 concentration then any teratogenicity or cytotoxicity 
observed in the FETAX is probably caused by a mechanism other than 
inhibition of gene expression. Should the test compound enhance the 
expression of the TK gene, this may be an indication that the substance 
is an inhibitor of DNA synthesis and DNA replication assays (presently 
being developed in our laboratory) should be performed to directly test 
for this possibility. If the substance proves to be an inhibitor of 
DNA synthesis in oocytes and is teratogenic in the FETAX experiment, 
then it is highly probable that the compound is a teratogen in other 
species as well. If a test agent does not affect DNA synthesis but 
inhibits RNA or protein synthesis in oocytes, then there is a distinct 
possibility that embryonic growth will be adversely affected in all 
species. In this manner, test results from both a validated whole 
embryo bioassay and a molecular test can complement one another to 
enhance the predictability of each assay. We are continuing to 
validate this system and feel that it holds great promise as a method 
of identifying genotoxic agents and understanding their teratogenic 
potential. 
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TABLE I. Effect of genotoxic agents on TK gene expression following exposure of the gene with the agent 
(Gene Exposure Assay). 
Inhibitor cpm of injec1- 2 3 Type of Concen- cpm of 1 % of control Results 
inhibitor tration ed control experimental 
Hydroxyurea DNA 10.0 72811 74672 103 NEG 
+12342.(5) +19507. (5) 
Cytosine Arabinoside DNA 6.0 167927 273185 163 NEG 
+16598.(3) +18330.(3) 
Ethidium Bromide DNA/RNA 0.2 184995 185913 100 NEG 
+86815. ( 3) +91651. (3) 
Actinomycin D RNA 0.025 168968 525 0 POS 
.:!:12322. (5) +371. (5) 
Cycloheximide Protein 0.0028 101116 112937 112 NEG 
_!9503. (3) +4668. (3) 
1cpm represents the amount of 3H-1MP bound to filter for the last time point during the reaction. Values 
are corrected for the cpm due to endogenous TK activity. Standard error represents the mean of 3-5 groups 
of oocytes from the same frog. Oocytes were injected then pooled and randomly divided into groups. Groups 
varied in number, ranging from 8-20 oocytes. Groups were homogenized in 10 µ1/oocyte. See "Materials and 
Methods" for details. 
2cpm of injected control 
cpm of experimental X 100 
3results based on inhibition of TK expression. 
....... 
°' 
TABLE II. Effect of genotoxic agents on TK gene expression following exposure of the oocyte with the agent 
(Oocyte Exposure Assay). 
Inhibitor Type of LC50 2 cpm of cpm of % of 4 
5 Concentra- 1 Results 
inhibitor tion (mg/ml) injecte1 experi3 control 
control mental 
Hydroxyurea DNA 2.0 l.82 38659 104223 270 NEG 
+4489. (3) +64994. (3) 
Cytosine 
Arabinoside DNA 2.0 6.0 71082 52891 74 NEG 
+33059. (3) +26586. (3) 
Ethidium DNA/RNA 0.02 0.05 71082 103114 145 NEG 
Bromide +33059.(3) ~18765. (3) 
Actinomycin RNA 0 .013 0.0189 194718 76434 39 POS 
Cycloheximide Protein 1.41_4 1.59 _4 106731 23099 22 POS 
x 10 x 10 +19104.(6) 
1Although different concentrations were tested, the concentration reported on the table was that concentra-
tion closest to the LC50 of the FETAX whole embryo bioassay (6). See justification in "Discussion" section. 
2LC50 value in mg/ml from FETAX bioassay (6). 
3 See comment lat end of Table I. 
4 See comment 2 at end of Table I. 
5 See comment 3 at end of Table I. ~ 
~ 
TABLE III. Effect of Genotoxic Agents on Thymidine Kinase Activity. 1 
Inhibitor Type of Concen- cpm of cpm of % of control Results 
Inhibitor tration Control Experimental 
(mg/ml) (cpm) (cpm) (%) 
Hydroxyurea DNA 10 .o 93679 101639 108 NEG 
Cytosine 
Arabinoside DNA 4.0 10321 9082 88 NEG 
Ethidium DNA/ 
Bromide RNA 0.2 38116 39562 104 NEG 
Actinomycin RNA 0.025 93679 90863 97 NEG 
Cyclohexi-
mide Protein 0.028 93679 96901 103 NEG 
1ooctyes were injected with the TK gene and incubated for 20 h. Following incuba-
tion the oocytes were homogenized and centrifuged as described in "Materials and 
Methods. The supernatants were divided into groups and the inhibitor added to the 
supernatant at the concentration indicated in the table. The control consisted of a 
group that received only buffer instead of inhibitor. Following treatment, the 
groups were assayed for thymidine kinase activity as described in "Materials and 
Methods". 
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Fig. 1. Gene exposure assay for hydroxyurea. pHSV-106 DNA was exposed 
to hydroxyurea prior to injection into oocytes. Hydroxyurea was 
removed from the DNA after exposure and the DNA was lyophilized to 
concentrate. The control group([]) was not lyophilized while the 
processed control (()) was lyophilized. 
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Fig. 2. Gene exposure assay for actinomycin D. pHSV-106 DNA was 
exposed to actinomycin D prior to injection. Actinomycin D not binding 
to the DNA was removed after exposure and the DNA was lyophilized to 
concentrate. The control group([]) was not lyophilized while the 
processed control ((i) was lyophilized. 
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Fig. 3. Oocyte exposure assay for actinomycin D. pHSV-106 DNA was 
injected into oocytes. The oocytes were then exposed to different 
concentrations of actinomycin D. 
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4 
Fig. 4. Gene exposure assay for cycloheximide. pHSV-106 DNA was 
exposed to cycloheximide prior to injection. Cycloheximide was removed 
from the DNA after exposure and the DNA was lyophilized to concentrate. 
The control group([]) was not lyophilized while the processed control 
(()) was lyophilized. 
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Fig. 5. Oocyte exposure assay for cycloheximide. pHSV-106 DNA was 
injected into oocytes. The oocytes were then exposed to different 
doses of cycloheximide. 
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ABSTRACT 
The teratogenic and growth inhibiting potential of DNA, RNA and 
protein synthesis inhibitors was explored using the Frog Embryo 
Teratogenesis Assay: Xenopus (FETAX). Endpoints measured in 96 h 
static tests were survival, malformation, ability to swim, skin 
pigmentation, stage of development and growth. The DNA synthesis 
inhibitors hydroxyurea, cytosine arabinoside and ethidium bromide 
proved to be teratogenic as measured by the teratogenicity index 
(LC50/EC50 malformation). The RNA synthesis inhibitor actinomycin D 
and the protein synthesis inhibitor cycloheximide were not particularly 
teratogenic but significantly inhibited growth as determined by 
head-tail length measurements and staging of embryos. The results were 
comparable to similar studies using mammalian embryos thereby helping 
to validate the use of Xenopus embryos as a rapid screening test 
for teratogenic chemicals found either in the environment or in the 
workplace. Advantages of using.Xenopus embryos as a screening test 
include rapid data collection, the ability to measure effects at 
different stages of development and the ability to use large number of 
embryos to obtain excellent dose-response curves with narrow confiden~e 
limits. 
Keywords: FETAX, Xenopus, Teratogenicity, Embryo Toxicity, 
Growth. 
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INTRODUCTION 
Approximately 50,000-70,000 chemicals are currently available in 
the marketplace with some 300 new chemicals released each year. Many 
of these chemicals pose a human health risk as well as a hazard to 
other organisms when these chemicals find their way into the 
environment. Short-term mutagenicity tests such as the Ames test ( 1) 
have been developed to test the mutagenicity and potential 
carcinogenicity of these compounds in a rapid and cost-effective 
manner. The development of similar short-term screening assays for 
teratogenicity has lagged behind mutagenicity assays but several 
systems are now being developed (2-5). Embryos of the South African 
Frog, Xenopus laevis, have been used previously as an assay 
system (6-9) but Dumont and co-workers have recently been responsible 
for both standardizing and validating this assay (10-12). They have 
named this the 11 FETAX 11 system (Frog Embryo Teratogenesis Assay: 
Xenopus) and we will also use this term in this work. 
Xenopus embryos offer numerous advantages as a screening 
assay. The frog embryo is a classical developmental system that 
undergoes many of the same developmental processes as mammalian 
embryos. Mating is inducible at any time during the year from 
commercially available frogs and development is external thereby 
permitting nondestructive analysis of malformation at different stages 
of development. Most of the endpoints are easily and quantitatively 
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determined within 96 h using simple conditioned water or buffer 
solutions to culture the embryos in. 
Because of the importance of gene expression in normal 
development, the possible teratogenic action of DNA, RNA and protein 
synthesis inhibitors have long been explored using a variety of 
experimental systems including mammals (13). Because of this previous 
work, these inhibitors can be used to help validate the FETAX system. 
For the purposes of this work, we define any inhibitor of normal gene 
expression as a genotoxic agent whether it works by attacking the 
structure of the gene or the cellular machinery that expresses the 
gene. Using this broad definition, all compounds used in this study 
qualify as genotoxic agents although under a more narrow definition 
only cytosine arabinoside, ethidium bromide and actinomycin D would be 
considered genotoxic since they alter DNA structure. Validation by 
using known teratogenic chemicals is one approach to extrapolating 
screening assay results from one system to another. Another approach 
is to determine which molecular mechanism is altered by a chemical and 
how this molecular mechanism relates to normal development. We have 
employed this combined approach to assess the teratogenicity of any 
genotoxic compound (14). By using complementary tests, we hope to 
raise the scientific and legal defensibility of short-term in 
vitro tests which have been lowly rated in the past (15). 
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In this study, we tested the effect of hydroxyurea, cytosine 
arabinoside, ethidium bromide, actinomycin D and cycloheximide on 
endpoints such as survival, gross malformation, ability to swim, skin 
pigmentation and growth after 96 hours of exposure in a static test. We 
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found that the DNA synthesis inhibitors hydroxyurea, cytosine 
arabinoside and ethidium bromide were teratogenic to varying degrees 
while the RNA synthesis inhibitor actinomycin D and the protein 
synthesis inhibitor cycloheximide were not teratogenic but inhibited 
growth. The FETAX assay meets most of the criteria set forth by Kimmel 
et al. (16) for short-term in vitro teratogenicity assays and 
the data from this study can be integrated with data from other in 
vitro genotoxicity assays (14). The teratogenicity results of this 
assay using genotoxic agents were similar to those obtained for these 
same agents in mammalian systems (l3). Complete validation of the 
FETAX system should provide a rapid, reliable and cost-effective 
screening assay for teratogenic substances. 
MATERIALS AND METHODS 
Water Quality 
The water for holding tanks of Xenopus adults and larvae was 
filtered through an activated carbon filter (Barnstead™) and aerated 
for 48 h prior to use. The water was routinely tested for pH, oxygen 
content, hardness, heavy metal content and total organic carbon. The 
test results indicated that the water was nontoxic (17). 
Animal Care and Breeding 
Adult Xenopus were obtained from Xenopus I®, Ann Arbor, 
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Mich. and stored in glass aquaria for a minimum of 30 days before use. 
Adults were fed beef liver and lung obtained from a local packing 
house. The meat was supplemented with baby vitamins (Polyvisol®) 
injected into the meat. Twelve h prior to mating, the female was 
injected with 1000 I.U. of human chorionic gonadotropin (Sigma®, St. 
Louis, Mo) and the male received 400 I.U. into the dorsal lymph sac. 
Amplexus ensued within 4-6 hand egg deposition 9-12 h from the time of 
injection. 
After breeding, the adults and any fecal material were removed 
from the tank and the embryos obtained by scraping the eggs into 55 mm 
plastic Petri dishes. The jelly coats of the embryos were removed by 
swirling for 2-3 min in a 2% w/v cysteine solution made up in aerated 
water and the pH adjusted to 8.1 with NaOH. 
Normally developing blastulae were initially selected by first 
removing them from necrotic eggs and abnormally cleaving embryos. A 
second selection was then performed to ensure that only normal embryos 
were used in the test. For each toxicant concentration, there were 2 
groups of embryos of twenty each placed into 55 mm glass Petri dishes. 
These dishes had previously been washed in dilute HCl, rinsed, then 
washed in dilute NaOH. This washing was followed by extensive rinsing. 
All glassware used in this study was washed in this manner. 
Test Substances 
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Test substances were dissolved at different concentrations in 
aerated tap water. All inhibitors were obtained from Sigma®, St. 
Louis, Mo •• It was necessary to adjust the pH of the cytosine 
arabinoside solution to 7.8 by adding 20 mM HEPES and adjusting the pH 
with NaOH. Solutions were changed once every 24 h after each set of 
observations were recorded. Great care was taken to prevent damage to 
the embryos during the change. This procedure was different from the 
technique of Dumont (10) who used the same solution for the entire 96 h 
test period. 
Data Collection 
At 24, 48 and 72 h the dead embryos were scored and removed from 
the dishes. The number malformed and the stage of development 
according to Neiuwkoop and Faber (18) were recorded. Death at 24 and 
48 h had to be ascertained by the embryo's skin pigmentation, 
structural integrity and irritability while at 72 and 96 h, the lack of 
heartbeat in the transparent embryo was an unambiguous sign of death. 
At 96 h, the number of dead and malformed embryos was recorded for 
each group. Survivors were rated on their ability to swim and those 
demonstrating phase two or greater swimming behavior (19) were judged 
to be defective. Swimming behavior is rated phase two when the larvae 
lose buoyancy and sink, when they spiral while sw1mm1ng or when they 
swim erratically. The dorsal pigmentation of each embryo was observed 
and those embryos exhibiting small melanophores or a reduced number of 
melanophores compared to controls were judged to be abnormally 
pigmented. 
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Surviving embryos were fixed in 0.5% formalin and the head-tail 
length of each embryo was measured using a Radio Shack® digitizer and 
the data input directly to a Radio Shack® model 16 microcomputer. 
Data Analysis 
The Litchfield-Wilcoxon (20) dose-response test was used to 
analyze the data for survival, malformation, swimming ability and skin 
pigmentation while the t Test for grouped observations was used to test 
for a significant reduction in growth. These statistical tests were 
part of a microcomputer software package (21) adapted by us for the 
analysis of these experiments. The software can perform all 
statistical tests, print and plot the results as well as store data 
relevant to the experiments. Additionally, a Visicalc® data entry 
model was developed to perform intermediate calculations. Any Radio 
Shack Model II, 12 or 16 microcomputer equipped with digitizer, and 
high resolution graphics board can run this software package which is 
available from the authors. Much of the programming is in Microsoft® 
Interpretive Basic and can easily be translated for other 
microcomputers. It will be necessary for the user to purchase 
Visicalc® from Radio Shack although this software package is optional. 
RESULTS 
Water Quality Analysis 
We designed our modification of the FETAX system so as to test the 
teratogenicity of any substance using pure substances or undiluted 
complex mixtures. This testing of complex mixtures made it necessary 
to use dechlorinated tap water to rear Xenopus embryos, larvae and 
adults. It was then necessary to routinely analyze the quality of the 
tap water. Table I shows the results for water quality analysis. 
Total organic carbon content of the carbon filtered tap water averaged 
3.6 mg/L which was was within allowable limits (17). Throughout the 
entire study, the malformation and death rate of control embryos (80 
control embryos/test) averaged less than 5% thereby indicating the 
water was nontoxic. 
Effect of DNA Synthesis Inhibitors on Growth and Development 
Inhibitors of DNA synthesis are potent teratogens (13) even though 
the mechanisms whereby they inhibit DNA synthesis may be different. 
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The DNA synthesis inhibitors used in this study were hydroxyurea, 
cytosine arabinoside and ethidium bromide. Hydroxyurea inhibits DNA 
synthesis by blocking the formation of deoxynucleotide triphosphates 
and has been proven to be a potent teratogen in mammalian systems 
(22,23). Cytosine arabinoside is a cytidine analog and is incorporated 
into the base structure of the DNA. It then inhibits DNA polymerase 
during replication. Cytosine arabinoside is also a potent teratogen in 
mammals (24,25). Ethidium bromide acts to inhibit replication by 
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intercalating into double stranded DNA and inhibiting polymerase 
function (26). However, the tertogenicity of ethidium bromide has not 
been fully established. As teratogens, DNA synthesis inhibitors may 
prevent the formation of sufficient cells in tissue primordia to permit 
proper development. The three compounds were selected not only because 
they could help validate the FETAX assay, but they would also provide 
information as to whether markedly different mechanisms of action 
affected the process of teratogenesis. 
Using FETAX to Assay for Teratogenicity 
When testing the effect of a genotoxin using the FETAX assay, we 
first exposed Xenopus larvae to various concentrations of genotoxin 
for 24 h. This procedure defined the upper limit of cytotoxicity of 
the test substance and provided an initial basis for establishing 
concentration ranges for the FETAX assay. Xenopus larvae were 
excellent indicator organisms of toxicity (19). 
The initial concentration range used was very broad for the first 
experiment in case the substance proved to be teratogenic. In this 
case, malformation would occur at concentrations of teratogen that were 
much lower than those causing embryo lethality. A broad concentration 
range would encompass both events. For hydroxyurea, the first 
experiment revealed a probable LC50 of about 2 mg/ml (Fig. 1). Two 
additional experiments were performed using additional groups within a 
more narrow concentration range. Figure 1 shows the FETAX system gave 
repeatable results even though different groups of breeding animals 
were used and the experiments were separated temporally. Usually, the 
second or third experiment had a sufficient number of groups that gave 
a response somewhere between 16 and 84% so that the Litchfield-
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Wilcoxon probit analysis could be performed on the mortality and 
malformation data from the third assay. The Litchfield-Wilcoxon test 
established the 96 h EC50 (malformation) for hydroxyurea of 0.425 mg/ml 
and the LC50 value of 1.82 mg/ml (Figure 2) with 95% confidence limits 
of 0.35-0.517 and 1.5-2.7 mg/ml respectively (Table II). From the data 
it can be seen that the concentrations at which malformation occurred 
were much lower than those needed to cause embryo lethality. The 
teratogenicity index for hydroxyurea was 4.3 indicative that a 
mechanism crucial to development was being inhibited and that general 
cytotoxicity was not involved in causing abnormal development (10). An 
index of one would suggest that general toxicity was causing both 
malformation and death. It should be noted that because of the large 
number of available embryos, an excellent data fit was possible with 
good confidence limits. In assaying for teratogenicity, we have found 
it expedient to follow the sequence listed above for hydroxyurea in 
performing the FETAX assay for mortality and malformation. This 
procedure was followed for all the compounds tested even though we only 
present dose-response data here from the third experiment. 
Figure 3 shows the change in the malformation curve through time. 
Because Xenopus development is external, it was possible to observe 
mortality and malformation.rates through time. This permitted much 
more data to be collected than in the case of mammalian or avian 
systems. For hydroxyurea, the slope of the dose-response curve for 
malformation did not change (Figure 3) but the entire curve was shifted 
to lower concentrations throughout the course of the experiment. The 
greatest shift in this experiment was seen between 24 and 48 h into the 
experiment. This suggested a stage sensitivity to hydroxyurea such 
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that early stages were more sensitive than later stages. These results 
may be consistent with the known mode of action of hydroxyurea which is 
inhibition of DNA synthesis (13) since the rate of cell division in 
amphibian embryos is very high during the first 48 h of development and 
then declines. We have also detected a noticeable reduction in the 
rate of development when inhibitors of DNA synthesis or other genotoxic 
agents are used. At high inhibitor concentrations, the embryos can lag 
behind by two full stages of development 48 h post-fertilization even 
though all other physical parameters are held constant. The effect was 
very similar to rearing one group of embryos at temperatures several 
degrees centigrade cooler than another. 
The Teratogenic Effects of Hydroxyurea 
Table II summarizes the results of the entire study and shows that 
for all dose-response data that can be analyzed by the Litchfield-
Wilcoxon method, narrow confidence limits can be set. For hydroxyurea, 
the LCSO and ECSO (malformation) data were clearly outside each other's 
confidence limits. This indicated a significant difference between the 
two curves and gave validity to the concept that the teratogenicity 
index was a meaningful measure of teratogenicity. 
The Teratogenic Effects of Cytosine Arabinoside 
Figure 4 shows the dose-response curve for the effect of cytosine 
arabinoside on mortality and malformation in buffered water. The LCSO 
and ECSO (malformation) was estimated to be 5.4 and 0.76 mg/ml 
respectively. The teratogenicity index was estimated to be about 7.1 
(Table II) and clearly showed that cytosine arabinoside was as 
teratogenic to frog embryos as it was in mammalian systems (24,25). 
Initial experiments with cytosine arabinoside indicated that high 
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concentrations lowered the pH of the water to about 3.5. The 
interaction of low pH and DNA synthesis inhibition yielded an LC50 of 
2.45 and an EC50 (malformation) of 0.2 mg/ml (data not shown). Raising 
the pH artificially above neutrality dramatically increased survival 
and allowed interpretation of the effect of cytosine arabinoside 
without regard to the interaction of pH. Although numerous test 
concentrations were used between 0.25 and 8.0 mg/ml for cytosine 
arabinoside only the two concentrations above 1.5 mg/ml in the 
malformation curve shown in Figure 4 exhibited significant death rates. 
The data for the effect of cytosine arabinoside on mortality and 
malformation was so disparate that there was no doubt that the two 
curves were not overl.apping and the teratogenicity index was 
significant. 
Effect of Cytosine Arabinoside on Swimming Ability and Skin 
Pigmentation 
Malformation was determined by viewing the entire embryo through a 
dissection microscope and observing gross malformations. It was 
possible that damage occurred to the embryo that was not detectable by 
this method. Swimming behavior and abnormal pigmentation were 
endpoints designed to show damage at the cellular levels (10). This 
type of damage was expected to occur at concentrations of teratogen 
lower than that needed to cause gross malformation. The 96 h EC50 
values for swimming ability and abnormal pigmentation were 1.3 and 1.48 
mg/ml respectively (Fig. 5). Although there was a close fit of the 
data, these values were much higher than the 0.76 mg/ml value for gross 
malformations (Table II). The reduction of pigmentation was estimated 
by noting the number and size of the melanophores on the back of each 
larvae. For cytosine arabinoside and actinomycin D, this procedure 
yielded good results but none of the other compounds used caused a 
reduction in pigmentation that occurred in a dose-response manner. 
Effect of Hydroxyurea and Cytosine Arabinoside on Growth 
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Both hydroxyurea and cytosine arabinoside affected embryonic 
growth at concentrations far lower than the EC50 (malformation) and 
LC50 (Figure 6). Only 0.3 mg/ml hydroxyurea and 0.8 mg/ml cytosine 
arabinoside significantly affected growth at the P=0.01 level as 
measured by head-tail length. Given the ability of each compound to 
inhibit DNA synthesis and, therefore, cell division, these results were 
expected. A reduction in growth certainly can compromise the prospects 
of survival for an organism. At high inhibitor concentrations, embryos 
were only 60-65% the length of controls. Both curves showed a good 
dose-response relationship between concentration and the corresponding 
reduction in growth. Table II also shows that both hydroxyurea and 
cytosine arabinoside had a multiplicity of effects but that growth was 
the most sensitive endpoint to these inhibitors followed by the 
occurrence of congenital malformations. 
The Teratogenic and Growth Inhibiting Effects of Ethidium Bromide 
Although the teratogenicity of ethidium bromide had not been 
extensively studied, it was used in this study because it affected DNA 
synthesis by a mechanism different from hydroxyurea and cytosine 
arabinoside (26). Table II shows that ethidium bromide did exhibit 
some teratogenicity as the teratogenicity index is almost 1.5 and the 
95% confidence limits for the mortality and malformation were separated 
from one another. As in the case of hydroxyurea and cytosine 
arabinoside, the 96 h EC50 (ability to swim) was not more sensitive 
than the EC50 (malformation). The effect of ethidium bromide on growth 
was greater as concentrations as low as 0.001 mg/ml significantly 
affected growth. As in the case of hydroxyurea, it was not possible to 
discern reduction in pigmentation (Table II). 
The Teratogenic and Growth Inhibiting Effects of Actinomycin Q 
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Actinomycin Dis a potent inhibitor of RNA synthesis while DNA 
synthesis is only inhibited at higher concentrations. Actinomycin D 
intercalates into the double helix of the DNA and prevents RNA 
polymerase from reading the genetic code. After a period of time, this 
would ultimately reduce protein synthesis. Actinomycin D 1s considered 
to be slightly to moderately teratogenic in mammalian systems (13). 
Figure 7 shows the effect of actinomycin Don mortality and 
malformation. The 96 h EC50 (malformation) and LCSO values were very 
similar and the teratogenicity index, in contrast to the DNA synthesis 
inhibitors, was 0.88 (Table II). Because the 95% confidence limits of 
the EC50 (malformation) overlapped with the confidence limits of the 
LC50 there was probably no significant difference between the two 
values and the teratogenicity index was not significant. 
Table II shows that actinomycin D affected swimming and 
pigmentation at concentrations similar to the EC50 (malformation) and 
LC50. Actinomycin D was required in higher concentrations to reduce 
growth than for either of the DNA synthesis inhibitors (Figure 8). The 
minimum concentration needed to reduce growth was 0.0159 mg/ml while 
the LC50 is 0.0189 mg/ml (Table II). Because this level was so near 
the LC50, embryo death occurred quickly and the amount of embryonic 
size reduction was restricted to only 80% of controls. Apparently, 
once the concentration was high enough so that the actinomycin D 
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penetrated the cell and nuclear membranes, death quickly ensued. This 
was in sharp contrast to the 30-40% growth reduction possible in assays 
using cytosine arabinoside and hydroxyurea (Figure 6). Actinomycin D 
may have several cellular side affects at or near the concentration 
needed to inhibit RNA synthesis so that general toxicity rapidly 
occurred (13). 
The Teratogenic and Growth Inhibiting Effects of Cycloheximide 
Cycloheximide inhibits protein synthesis at the level of the 
ribosome. In mammalian systems, cycloheximide is considered not to be 
teratogenic but rather an inhibitor of embryonic growth (13). This was 
also true for its effect on Xenopus embryos. Figure 9 shows the 
effect of cycloheximide on mortality and malformation. There was a 
close correlation between the two dose-response curves (96 h EC50 
(malformation) 1.34 x 10-4 mg/ml; 96 h LC50 1.59 x 10-4 mg/ml) and 
the teratogenicity index was only 1.17 which was again within the 
confidence limits of the two curves. The 96 h EC50 swimming was 1 x 
-4 10 mg/ml and showed that cycloheximide affected swimming behavior 
at concentrations only slightly lower than the LC50 or EC50 values 
(Table II). It was not possible to accurately judge the pigmentation 
pattern of these embryos as all embryos even in low concentrations were 
whitish in appearance. This does not necessarily mean that they were 
lacking pigment but that it was difficult to see the pigmentation 
pattern. 
Cycloheximide affects growth in a manner similar to hydroxyurea 
and cytosine arabinoside (Fig. 10, Table II). The minimum 
concentration of cycloheximide required to inhibit growth at the P = 
0.01 level was 5.6 x 10-5 mg/ml which was quite dissimilar from the 
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-4 LC50 value of 1.59 x 10 mg/ml. Small quantities of cycloheximide 
were then very effective 1n reducing embryonic growth and this was 
consistent with findings in mammalian systems (13). 
In summary, except for the mortality curve of cytosine ara-
binoside, all data gave good dose-response results that could be 
extrapolated to both zero and maximum effects (Table II). The 95% 
confidence limits were all narrow which was mainly a of result large 
sample sizes tested at each concentration. In all cases, growth was the 
most sensitive criterion of toxicity followed by combined congenital 
malformations. Lastly, the DNA synthesis inhibitors proved to be 
teratogenic as evidenced by their teratogenicity indices while 
actinomycin D and cycloheximide proved to mainly inhibit growth. 
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DISCUSSION 
The FETAX System as~ Teratogenicity Assay 
The assay, as we have employed it, differed from that of Dumont 
and coworkers (10) 10 that we used dechlorinated tap water instead of a 
buffer solution for rearing embryos. We also dejellied the eggs 
whereas Dumont et al. (10) did not. The toxic chemicals in our assay 
were changed once every 24 h with data being collected on mortality and 
malformation at that time or just after 96 h. We also used covered 55 
mm glass Petri dishes instead of larger finger bowls. Moreover, we 
included malformed with normal embryos in the growth length estimates 
so as to include the entire surviving population. Other than these 
differences, our assay was essentially the same to that proposed by 
Dumont et al. (10). 
In its present form, this assay meets most of the criteria set 
forth by Kimmel et al. (16) for validation of in vitro 
teratogenicity assays. Endpoints such as mortality, malformation, 
absence of swimming and growth are easily quantifiable, capable of 
being analyzed statistically and of exhibiting a dose-response 
relationship with the establishment of narrow confidence limits. Since 
many of the stages of amphibian development are similar to mammalian 
development, this assay should provide teratogenicity data highly 
relevant to humans although the problems of maternal metabolism and 
placental transport must be considered in this as well as all other 
in vitro assays. Using FETAX it is also possible to determine 
what stage of development is affected because development is external 
and the suspected teratogen can be added at any time during 
development. Further experimentation must be performed before 
compounds requiring metabolic activation can be used in this assay and 
this remains a current, but temporary, limitation. 
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Because of their lack of sensitivity, the use of the ability to 
swim and skin pigmentation endpoints will produce little additional 
data unless new criteria are used to estimate swimming ability and skin 
pigmentation. For swimming ability, it may be necessary to measure the 
negative phototactic response of the 4 day larvae following treatment 
instead of merely estimating the ability of each larva to swim normally 
in a straight line. In the case of skin pigmentation, it will be 
necessary to quantify both the number and size of the melanophores on 
the back of each larva. A rapid and straightforward method of analysis 
is required in order to routinely use this endpoint to predict stress 
on the organism. 
In order to be useful for assaying the numerous compounds present 
in the environment, a bioassay must be both time and cost-effective. 
By using the microcomputer software package that we developed for the 
FETAX, we have significantly cut labor costs as well as standardized 
data handling and statistical procedures. The time savings makes it 
practical to carry out the entire assay from set-up to final data 
analysis in a single 5 day work week. Additional savings in time and 
costs must be forthcoming in order for teratogenicity screening assays 
to be routinely employed. 
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The Teratogenicity Index as~ Predictor of Teratogenic Potential 
The Teratogenicity Index (LC50/EC50 (malformation)) as proposed by 
Dumont et al. (10) may well be useful as a measure of teratogenic risk 
if species sensitivity and differences 1n metabolic activation are 
taken into account. Most teratogens will cause both malformation and 
embryo death. At low concentration, the compound may selectively 
interrupt a vital morphogenetic process or cause a selective necrosis 
of cells in a primordium, yet not affect the bulk of the cells that are 
not specifically engaged in development. In this situation, 
malformation frequently occurs with little mortality, resulting in a 
substantial teratogenic risk. At higher concentrations, all cells are 
similarly affected due to the general cytotoxicity component of the 
compound and although malformation occurs frequently, the number of 
dead embryos increases dramatically. In this case, there is much less 
teratogenic risk because there are very few live births and the problem 
is primarily one of embryo lethality. 
Species sensitivity becomes important when the assay species is 
tolerant to a particular compound compared to other more sensitive 
species. One way this may occur is when the teratogen is not rapidly 
transported into the body of the assay species but is easily taken up 
by more sensitive species. However, in both cases the teratogenicity 
index would be likely to remain the same as the low rate of teratogen 
uptake in the assay species affects both intracellular concentrations 
at which malformation and mortality occur equally. This same ratio may 
then exist for a more sensitive species that takes up the compound more 
quickly from the environment. The compound is still teratogenic by the 
same ratio although smaller doses are needed to produce the effect. 
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Regardless of species sensitivity, the chance of producing live 
malformed offspring is much higher for a compound with a high 
teratogenicity index than one with a low index where embryo death 
predominates. Comparisons should be made between diverse species to 
determine whether the teratogenicity index is the same for each 
validation compound. If so, this teratogenicity index could play a 
valuable role in predicting teratic risks. Unfortunately, situations 
will probably be encountered where differences in metabolism and 
development will produce a different teratogenicity index from one 
species to another thus generating false negative and positives. If 
these differences can be understood by further experimentation, then 
the predictability of short-term teratogenicity assays can be enhanced. 
Sensitivity of Xenopus Embryos to Test Compounds 
The sensitivity of Xenopus embryos to inhibitors of DNA, RNA 
and protein synthesis was fairly good despite the presence of the 
rather inert vitelline membrane which was a permeability factor during 
the first 20 h of development. For hydroxyurea, cytosine arabinoside 
and ethidium bromide, the minimum concentrations needed to 
significantly affect growth was 0.3, 0.8 and 0.001 mg/ml respectively 
while the amount needed to reduce either DNA synthesis or cell growth 
in cultured cells was 0.04 (27), 0.028 (28) and 5 x 10-5 mg/ml (29). 
Actinomycin D has a molecular weight of 1255.S and should therefore 
pass relatively slowly through cell membranes. Since cultured mouse 
blastocysts have only a few cells, they should be far more sensitive to 
this inhibitor than whole Xenopus embryos composed of thousands of 
cells and this was borne out in this study. It took 0.0159 mg/ml 
actinomycin D to inhibit Xenopus embryonic growth while only 5 x 
10-6 mg/ml was needed to inhibit the growth of cultured mouse 
blastocysts (30). For the lower molecular weight compound 
cycloheximide, 5.6 x 10-5 mg/ml cycloheximide was required to inhibit 
Xenopus growth while -6 only l x 10 mg/ml was required for 
cultured mouse blastocysts (30). While somewhat more tolerant than 
cultured cells and early cultured mammalian embryos, it appears that 
the FETAX assay promises to be acceptably sensitive to potential 
teratogens. Most of the differences in sensitivity may be due to the 
increased number of cells present in late stage Xenopus embryos, 
the relative impermeability of the early vitelline membrane and the 
probable detoxification of toxins by late stage embryos. 
FETAX Results Are Similar to Those Obtained Using Mammals 
The overall conclusions of this study are essentially the same as 
in similar studies using mammals (13). Inhibitors of DNA synthesis 
were teratogenic regardless of their molecular mechanism of action. 
Actinomycin D and cycloheximide exhibited little or no teratogenicity 
but caused a marked decrease in growth. Most of the mammalian studies 
that will be compared below with the FETAX study involved single doses 
of teratogen or a treatment that lasted only a few days while in this 
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study the treatment was continuous. This is one difference that causes 
some caution in comparing FETAX results with mammalian studies. 
Hydroxyurea was as teratogenic in Xenopus as it was in 
mammals. The cytotoxic component of hydroxyurea reported in rats (22) 
and monkeys (23) may have been detected in this study. The 
teratogenicity index for hydroxyurea was 4.3 while that for cytosine 
arabinoside was 7.1 (Table II). The reduced teratogenicity index for 
hydroxyurea suggests that hydroxyurea is more cytotoxic than cytosine 
arabinoside. In the hydroxyurea tests, malformations occurred in the 
same concentration ranges as embryo lethality whereas in the cytosine 
arabinoside tests the ranges were clearly distinct (Figs. 2 and 4). 
Cytosine arabinoside was the most teratogenic inhibitor studied. 
The wide separation of mortality and malformation concentration ranges 
for cytosine arabinoside was also seen in experiments using rat 
embryos. Ritter et al., (25) reported that at concentrations where 
only 21% of the rat embryos died, cytosine arabinoside caused 100% 
malformation. The low toxicity of this analog clearly increases the 
risk of producing congenital malformations. 
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Ethidium bromide was also teratogenic in this study and there is 
evidence that it causes malformation in other systems (31). Ethidium 
bromide may not have intercalated efficiently into the embryonic genome 
and high concentrations could have been required to permit substantial 
DNA intercalation. At these elevated concentrations, ethidium bromide 
could have been cytotoxic thereby producing a relatively low 
teratogenicity index compared to the other DNA synthesis inhibitors. 
Actinomycin D caused numerous malformations in Xenopus embryos 
but it was also quite toxic as well as evidenced by the teratogenicity 
index of 1 or less (Table II). In rats, acute actinomycin D treatment 
also causes numerous resorptions as well as significant numbers of 
malformations (32,33). When the teratogenicity index is calculated 
from the experimental data for rats (33), the teratogenicity index is 
less than one. This compares favorably to the results reported in this 
study. Results of mammalian studies using chronic doses of actinomycin 
D parallel acute studies but maternal lethality prevents a complete 
dose-response study from being carried out (32). The FETAX assay has 
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no such limitation. Actinomycin D also reduces rat embryonic size (13) 
as it reduces Xenopus embryonic size (Fig. 8). 
Cycloheximide also caused malformations in Xenopus embryos 
only in the range of general toxicity. Its affect on growth was 
dramatic (Fig. 10) and these results are the same as for other 
mammalian studies investigating protein synthesis inhibitors (13, 34). 
The results show that the FETAX system accurately predicted 
teratogenicity in this study with no false positives or negatives when 
compared to mammalian studies. Actinomycin D may be an exception and 
further tests using mammalian systems should be performed to explore 
the dose-response relationships that exist between mortality and 
malformation. The data presented here were more quantitative than most 
mammalian studies and were based on results from hundreds of animals. 
Much additional validation with known mammalian teratogens needs to be 
performed before this system can be a reliable predictor of 
teratogenicity for mammals. 
Validation with known mammalian teratogens is one method that 
permits extrapolation of test results implying teratic risk to other 
organisms. Another method is to clearly understand the molecular 
mechanisms that underlie teratogenesis. DNA synthesis inhibitors 
routinely seem to be teratogenic (13). Should a compound prove to be a 
DNA synthesis inhibitor and also cause numerous malformations in the 
FETAX assay, then this is a more powerful argument for the agent 
causing human teratogenicity than just the results of the bioassay 
alone. If the compound causes a reduction in RNA and/or protein 
synthesis without altering DNA synthesis and the teratogenicity index 
is from the FETAX assay is approximately one, then growth inhibition 
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and embryo death are the hazards presented to the embryo. We have 
therefore combined the FETAX screening assay with another assay that 
routinely measures whether a compound can interfere with gene 
expression and whether this interference is due to the agent binding 
with the DNA or upsetting the metabolic machinery that produces the 
protein (14). This approach should not only make risk assessment 
easier but should also expand our data base for the molecular action of 
chemical teratogens. 
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Appendix 
Probit Analysis 
The probit transformation is commonly used to straighten 
cunnnulative curves such as obtained for dosage mortality and 
malformation data. It is merely a type of regression analysis. A 
probit is a unit of probability. It is related to the percent area 
under the normalized probability curve. The percent of animals 
responding is converted to probits. A 50% response would yield a 
probit of 5.0, based the fact that the 50% point is equivalent to O 
standard deviations coded by the addition of 5. The 83.14 point on a 
cunnnulative curve becomes +l standard deviation, and the probit value 
is 6.0. Using this method, cummulative curves can readily be 
linearized. 
Because there are no probit values corresponding to O and 100% 
effects, the problem of analyzing such complete dose-effect curves was 
addressed by Litchfield and Wilcoxon (20). The method of Litchfield 
and Wilcoxon was used in this study and this method is available as a 
computer program (21). In this study, this procedure was programmed 
into a Radio Shack TRS-80, Model 16, Microcomputer by the 
investigators. The program then determines the LC50 and EC50 
(malformation) values as well as the 95% confidence limits. 
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1.21 
Table I. Water quality analysis of carbon-filtered contlitioned tap water 
used to maintain adults and embryos. 
1 Sample 
Sample 
Sample 
Sample 
Sample 
Sample 
Sample 
Sample 
Sample 
Semple 
Sample 
1 
2 
3 
4 
5 
1 
2 
3 
4 
5 
1 Samples 
average 
maximum 
minimum 
average 
maximum 
minimum 
Na 
(mg/1) 
22 
21.8 
21.8 
19.8 
18.6 
20.8 
22 
18.6 
Cu 
(mg/1) 
0.04 
0.04 
0.04 
0.008 
0.007 
0.027 
0.04 
0.007 
Ca 
(mg/1) 
42 
44.6 
46.4 
42.6 
41.6 
43.44 
46.4 
41.6 
Cr 
(mg/1) 
0.006 
0.023 
0.04 
0.024. 
0.005 
0.02 
0.04 
0.005 
Mg 
(mg/1) 
12.7 
13.5 
12.5 
12.62 
13.07 
12.88 
13.5 
12.5 
Ni 
(mg/1) 
0.05 
0.05 
0.05 
0.004 
0.008 
0 .032 
0.05 
0.004 
K 
(mg/1) 
5.6 
5.5 
5.4 
4.6 
5.28 
.5 .28 
5.6 
446 
Cd 
(mg/1) 
0.001 
0.001 
0.001 
0.001 
0.001 
0.001 
0.001 
0.001 
F'e 
(mg/1) 
0.02 
0.03 
0~11 
0.12 
0.07 
o.oi-
0.12 
0.02 
Oxygen 
(mg/l.) 
5.5 
5.8 
5.1 
6.0 
4.8 
5.56 
6 
4.8 
Pb 
{mg/1) 
<0.005 
<0.005 
<0.005 
0.008 
0.007 
(0.006 
0.008 
0.005 
Conduct-
ivity 
(µMHOS) 
229 
219 
220 
212 
212 
218.4 
229 
212 
Zn 
(ng/ 1) 
<0.03 
<0.03 
<0.03 
0.002 
0.009 
<0.02 
0.03 
0.002 
pH 
8.08 
8 .1 
8.08 
8.15 
7.8 
8.04 
8.15 
7.8 
for water quality analysis were randomly collected from tap water 
during the 6 month period that the data was collected for these experiments. 
Oxygen, conductivity and pH measurements were performed on water samples 
actually used for ex~erimentation. 
Table II. Effects of genotoxic agents on embryo mortality, malformation, teratogenicity index, swimming 
ability, pigmentation and growth. 
Assay Hydroxyurea Cytosine Ethidium Actinomycin D Cycloheximide 
arabinoside bromide 
-2 -4 (mg/ml) (mg/ml) (mg/ml) (mg/mlxlO ) (mg/mlxlO ) 
LC50 1.82 6.0 0.05 1.89 1.59 
95% Confidence Interval 1.5-2. 7 N.A. 0.047-0.054 1.38-2. 61 1.03-2. 34 
EC 50 (Malformation) 0.43 0.76 0.035 2.17 1.34 
95% Confidence Interval 0.35-0.52 0.63-0.93 0.029-0.043 1.88-2.51 1.06-1.87 
Teratogenicity Index 1 
(Lc50 /Ec 50 Malformation) 4.3 7.9 1.43 0.88 1.17 
Ec 50 (Swimming Ability) 0.58 1.3 0.05 1. 76 1.0 
95% Confidence Interval 0.47-0. 72 1.13-1.49 N.A. 0.008-3.8 0.52-1.9 
Ec 50 (Pigmentation) - 1.48 - 2.18 
95% Confidence Interval - 1. 28-1.59 1. 68-2.81 
Minimum Concentration to Inhibit Growth 2 0.3 0.8 0.001 1.59 0.56 
Minimum Concentr1tion to Inhibit 
Development 0.6 0.7 0.05 1.59 0. 28 
N.A.: Data not available. Value determined by 2 point method. 
IT ' . . d 1 d' . 1 eratogen1c1ty in ex va ues are 1mens1on ess 
2values are minimum concentrations that inhibit growth (t test for grouped observatio.ns at P=0.01. 
3values are concentrations at which development is retarded by 1 stage after 24 H development. 
..... 
N 
N 
Fig. 1. Effect of hydroxyurea on mortality. The number of dead 
embryos after 96 h exposure was recorded by observing the cessation of 
heartbeat. 
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Fig. 2. Dose-response curve of the effect of hydroxyurea on 
Xenopus mortality and malformation. The teratogenicity index was 
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Fig. 3. Dose-response curve of the effect of hydroxyurea on 
malformation over time. 
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Fig. 4. Dose-response curve of the effect of cytosine arabinoside on 
Xenopus mortality and malformation. The teratogenicity index was 
7.1. The mortality curve was determined by the two point method due to 
insufficient data points in the 16-84% mortality region. 
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Fig. 5. Dose-response curve of the effect of cytosine arabinoside on 
larval ability to swim an~ skin pigmentation after 96 h exposure. 
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Fig, 6. Effect of hydroxyurea and cytosine arabinoside on growth as 
measured by head-tail lengths after 96 h exposure. 
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Fig. 7. Dose-response curve of the effect of actinomycin Don 
Xenopus mortality and malformation. The teratogenicity index was 
0.88. 
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Fig. 8. Effect of actinomycin Don growth as measured by head-tail 
lengths after 96 h exposure. 
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Fig. 9. Dose-response curve of the effect of cycloheximide on 
Xenopus mortality and malformation. The teratogenicity index was 
1.17. 
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Fig. 10. Effect of cycloheximide on growth as measured by head-tail 
lengths after 96 h exposure. 
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